Document and Entity Information
Document and Entity Information - shares | 6 Months Ended | |
Jun. 30, 2021 | Aug. 07, 2021 | |
Details | ||
Registrant CIK | 0000701869 | |
Fiscal Year End | --12-31 | |
Document Type | 10-Q | |
Document Quarterly Report | true | |
Document Period End Date | Jun. 30, 2021 | |
Document Transition Report | false | |
Entity File Number | 001-32244 | |
Entity Registrant Name | INDEPENDENCE HOLDING COMPANY | |
Entity Incorporation, State or Country Code | DE | |
Entity Tax Identification Number | 58-1407235 | |
Entity Address, Address Line One | 96 CUMMINGS POINT ROAD | |
Entity Address, City or Town | STAMFORD | |
Entity Address, State or Province | CT | |
Entity Address, Postal Zip Code | 06902 | |
City Area Code | 203 | |
Local Phone Number | 358-8000 | |
Title of 12(b) Security | Common Stock, $1.00 par value | |
Trading Symbol | IHC | |
Security Exchange Name | NYSE | |
Entity Current Reporting Status | Yes | |
Entity Interactive Data Current | Yes | |
Entity Filer Category | Accelerated Filer | |
Entity Small Business | true | |
Entity Emerging Growth Company | false | |
Entity Shell Company | false | |
Entity Common Stock, Shares Outstanding | 14,644,389 | |
Amendment Flag | false | |
Document Fiscal Year Focus | 2021 | |
Document Fiscal Period Focus | Q2 |
Consolidated Balance Sheets
Consolidated Balance Sheets - USD ($) $ in Thousands | Jun. 30, 2021 | Dec. 31, 2020 |
Investments | ||
Short-term Investments | $ 1,550 | $ 1,568 |
Securities Purchased under Agreements to Resell | 70,323 | 33,038 |
Debt Securities, Available-for-sale | 183,709 | 210,719 |
Equity Securities, FV-NI, Current | 0 | 1,753 |
Other Investments | 2,022 | 1,928 |
Investments | 257,604 | 249,006 |
Cash and Cash Equivalents, at Carrying Value | 22,834 | 31,923 |
Equity Method Investments | 33,762 | 0 |
Premiums Receivable, Net | 10,950 | 9,981 |
Reinsurance Recoverables, Including Reinsurance Premium Paid | 354,735 | 357,237 |
Goodwill | 12,486 | 12,486 |
Escrow Deposit | 78,779 | 0 |
Other Assets | 29,864 | 46,832 |
Disposal Group, Including Discontinued Operation, Assets | 416,162 | 375,691 |
Assets, Total | 1,217,176 | 1,083,156 |
Liabilities | ||
Liability for Claims and Claims Adjustment Expense | 127,815 | 132,957 |
Liability for Future Policy Benefit, before Reinsurance | 196,026 | 198,086 |
Deposit Contracts, Liabilities | 142,155 | 141,376 |
Unearned Premiums | 1,763 | 1,952 |
Policyholder Account Balance | 11,988 | 12,001 |
Reinsurance Payable | 2,242 | 3,872 |
Other Liabilities | 66,519 | 44,855 |
Disposal Group, Including Discontinued Operation, Liabilities | 120,180 | 75,939 |
Liabilities | 668,688 | 611,038 |
Redeemable Noncontrolling Interest, Equity, Common, Carrying Amount | 0 | 2,312 |
TOTAL LIABILITIES AND EQUITY | 1,217,176 | 1,083,156 |
STOCKHOLDERS' EQUITY: | ||
Preferred Stock, Value, Issued | 0 | 0 |
Common Stock, Value, Issued | 18,625 | 18,625 |
Additional Paid in Capital, Common Stock | 125,653 | 124,757 |
Accumulated Other Comprehensive Income (Loss), Net of Tax | 3,220 | 4,197 |
Treasury stock, at cost; 3,981,069 and 3,982,411 shares | 77,189 | 77,088 |
Retained Earnings (Accumulated Deficit) | 478,139 | 399,273 |
TOTAL IHC STOCKHOLDERS' EQUITY | 548,448 | 469,764 |
Stockholders' Equity Attributable to Noncontrolling Interest | 40 | 42 |
TOTAL EQUITY | $ 548,488 | $ 469,806 |
Consolidated Balance Sheets - P
Consolidated Balance Sheets - Parenthetical - $ / shares | Jun. 30, 2021 | Dec. 31, 2020 |
Details | ||
Preferred Stock, Par or Stated Value Per Share | $ 1 | $ 1 |
Preferred Stock, Shares Authorized | 100,000 | 100,000 |
Preferred Stock, Shares Outstanding | 0 | 0 |
Common Stock, Par or Stated Value Per Share | $ 1 | $ 1 |
Common Stock, Shares Authorized | 23,000,000 | 23,000,000 |
Common Stock, Shares, Issued | 18,625,458 | 18,625,458 |
Common Stock, Shares, Outstanding | 14,644,389 | 14,643,047 |
Treasury Stock, Shares | 3,981,069 | 3,982,411 |
Consolidated Income Statement
Consolidated Income Statement - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2021 | Jun. 30, 2020 | Jun. 30, 2021 | Jun. 30, 2020 | |
Revenues | ||||
Premiums Earned, Net | $ 42,451 | $ 49,138 | $ 86,023 | $ 99,804 |
Net Investment Income | 1,651 | 2,329 | 3,452 | 4,828 |
Insurance Commissions and Fees | 4,944 | 3,907 | 11,079 | 7,341 |
Other Income | 410 | 807 | 1,026 | 1,432 |
Gain (Loss) on Investments | (126) | 274 | 91 | 117 |
Revenues | 49,330 | 56,455 | 101,671 | 113,522 |
Operating Expenses | ||||
Policyholder Benefits and Claims Incurred, Net | 17,192 | 21,339 | 39,113 | 47,628 |
Selling, General and Administrative Expense | 32,842 | 37,974 | 63,602 | 69,034 |
Benefits, Losses and Expenses | 50,034 | 59,313 | 102,715 | 116,662 |
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | (704) | (2,858) | (1,044) | (3,140) |
Income Tax Expense (Benefit) | (267) | (1,066) | (430) | (1,187) |
Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | (437) | (1,792) | (614) | (1,953) |
Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | ||||
Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax | 92,375 | 3,594 | 99,574 | 9,243 |
Discontinued Operation, Tax Effect of Discontinued Operation | 15,570 | 1,264 | 17,026 | 2,430 |
Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | 76,805 | 2,330 | 82,548 | 6,813 |
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | 76,368 | 538 | 81,934 | 4,860 |
Net Income (Loss) Attributable to Nonredeemable Noncontrolling Interest | (1) | 43 | (2) | 34 |
Net Income (Loss) Attributable to Redeemable Noncontrolling Interest | (102) | 74 | (156) | 127 |
Net Income (Loss) Attributable to Parent | $ 76,471 | $ 421 | $ 82,092 | $ 4,699 |
Earnings Per Share, Basic | ||||
Income (Loss) from Continuing Operations, Per Basic Share | $ (0.03) | $ (0.12) | $ (0.04) | $ (0.13) |
Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share | 5.25 | 0.15 | 5.65 | 0.45 |
Earnings Per Share, Basic | $ 5.22 | $ 0.03 | $ 5.61 | $ 0.32 |
Weighted Average Number of Shares Outstanding, Basic | 14,642 | 14,765 | 14,641 | 14,811 |
Earnings Per Share, Diluted | ||||
Income (Loss) from Continuing Operations, Per Diluted Share | $ (0.03) | $ (0.12) | $ (0.04) | $ (0.13) |
Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share | 5.25 | 0.15 | 5.65 | 0.45 |
Earnings Per Share, Diluted | $ 5.22 | $ 0.03 | $ 5.61 | $ 0.32 |
Weighted Average Number of Shares Outstanding, Diluted | 14,642 | 14,765 | 14,641 | 14,811 |
Condensed Consolidated Statemen
Condensed Consolidated Statement of Comprehensive Income - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2021 | Jun. 30, 2020 | Jun. 30, 2021 | Jun. 30, 2020 | |
Details | ||||
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | $ 76,368 | $ 538 | $ 81,934 | $ 4,860 |
OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax | ||||
OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax | 1,212 | 2,227 | (1,248) | 2,093 |
OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, Tax | 260 | 474 | (271) | 451 |
OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax | 952 | 1,753 | (977) | 1,642 |
Other Comprehensive Income (Loss), Net of Tax | 952 | 1,753 | (977) | 1,642 |
Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest | 77,320 | 2,291 | 80,957 | 6,502 |
Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest | ||||
Net Income (Loss) Attributable to Noncontrolling Interest | (103) | 117 | (158) | 161 |
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest | 0 | 0 | 0 | 0 |
Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest | (103) | 117 | (158) | 161 |
Comprehensive Income (Loss), Net of Tax, Attributable to Parent | $ 77,423 | $ 2,174 | $ 81,115 | $ 6,341 |
Condensed Consolidated Statem_2
Condensed Consolidated Statement of Stockholders' Equity - USD ($) $ in Thousands | Total | COMMON STOCK, AMOUNT | Additional Paid-in Capital | AOCI Attributable to Parent | Treasury Stock | Retained Earnings | Parent | Noncontrolling Interest |
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Dec. 31, 2019 | $ 459,712 | $ 18,625 | $ 122,717 | $ 1,212 | $ (69,724) | $ 386,864 | $ 459,694 | $ 18 |
Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest | 4,733 | 4,699 | 4,699 | 34 | ||||
Other Comprehensive Income (Loss), Net of Tax | 1,642 | 1,642 | 1,642 | 0 | ||||
Dividends, Common Stock, Cash | 3,246 | 3,246 | 3,246 | 0 | ||||
Sharebased Compensation Effect On Stockholders Equity | 1,087 | 1,087 | 1,087 | 0 | ||||
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Jun. 30, 2020 | 459,324 | 18,625 | 123,804 | 2,854 | (74,325) | 388,317 | 459,275 | 49 |
Treasury Stock, Value, Acquired, Cost Method | 4,601 | 4,601 | 4,601 | 0 | ||||
Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders | 3 | 0 | 3 | |||||
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Mar. 31, 2020 | 459,898 | 18,625 | 123,260 | 1,101 | (71,196) | 388,102 | 459,892 | 6 |
Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest | 464 | 421 | 421 | 43 | ||||
Other Comprehensive Income (Loss), Net of Tax | 1,753 | 1,753 | 1,753 | 0 | ||||
Dividends, Common Stock, Cash | 206 | 206 | 206 | 0 | ||||
Sharebased Compensation Effect On Stockholders Equity | 544 | 544 | 544 | 0 | ||||
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Jun. 30, 2020 | 459,324 | 18,625 | 123,804 | 2,854 | (74,325) | 388,317 | 459,275 | 49 |
Treasury Stock, Value, Acquired, Cost Method | 3,129 | 3,129 | 3,129 | 0 | ||||
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Dec. 31, 2020 | 469,806 | 18,625 | 124,757 | 4,197 | (77,088) | 399,273 | 469,764 | 42 |
Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest | 82,090 | 82,092 | 82,092 | (2) | ||||
Other Comprehensive Income (Loss), Net of Tax | (977) | (977) | (977) | 0 | ||||
Dividends, Common Stock, Cash | 3,226 | 3,226 | 3,226 | 0 | ||||
Sharebased Compensation Effect On Stockholders Equity | 935 | 896 | 39 | 935 | 0 | |||
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Jun. 30, 2021 | 548,488 | 18,625 | 125,653 | 3,220 | (77,189) | 478,139 | 548,448 | 40 |
Treasury Stock, Value, Acquired, Cost Method | 140 | 140 | 140 | 0 | ||||
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Mar. 31, 2021 | 473,789 | 18,625 | 125,189 | 2,268 | (77,228) | 404,894 | 473,748 | 41 |
Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest | 76,470 | 76,471 | 76,471 | (1) | ||||
Other Comprehensive Income (Loss), Net of Tax | 952 | 952 | 952 | 0 | ||||
Dividends, Common Stock, Cash | 3,226 | 3,226 | 3,226 | 0 | ||||
Sharebased Compensation Effect On Stockholders Equity | 503 | 464 | 39 | 503 | 0 | |||
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Jun. 30, 2021 | $ 548,488 | $ 18,625 | $ 125,653 | $ 3,220 | $ (77,189) | $ 478,139 | $ 548,448 | $ 40 |
Condensed Consolidated Statem_3
Condensed Consolidated Statement of Stockholders' Equity - Parenthetical - $ / shares | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2021 | Jun. 30, 2020 | Jun. 30, 2021 | Jun. 30, 2020 | |
Details | ||||
Common Stock, Dividends, Per Share, Declared | $ 0.22 | $ 0.22 | $ 0.22 | $ 0.22 |
Consolidated Statement of Cash
Consolidated Statement of Cash Flows - USD ($) $ in Thousands | 6 Months Ended | |
Jun. 30, 2021 | Jun. 30, 2020 | |
CASH FLOWS PROVIDED BY (USED BY) OPERATING ACTIVITIES: | ||
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | $ 81,934 | $ 4,860 |
Net Cash Provided by (Used in) Operating Activities | 53,535 | 28,247 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect | (47,768) | (428) |
Adjustments to reconcile net income to net change in cash from | ||
Discontinued Operation, Gain (Loss) from Disposal of Discontinued Operation, before Income Tax | (74,534) | 0 |
Discontinued Operation, Provision for Loss (Gain) on Disposal, before Income Tax | 812 | 0 |
Deferred Policy Acquisition Costs, Amortization Expense | 425 | 166 |
Investment Income, Net, Amortization of Discount and Premium | (1,139) | (1,218) |
Gain (Loss) on Investments | 91 | 117 |
Depreciation, Depletion and Amortization, Nonproduction | 908 | 759 |
Other Noncash Income (Expense) | (17,107) | (2,393) |
Increase (Decrease) in Operating Capital | ||
Increase (Decrease) in Insurance Liabilities | 37,333 | 27,057 |
Increase (Decrease) in Premiums Receivable | 15,141 | 8,253 |
Increase (Decrease) in Contract with Customer, Asset | 1,006 | 0 |
Increase (Decrease) in Reinsurance Recoverable | (2,663) | (3,725) |
Change in Claim Fund Balances | (1,022) | 574 |
Increase (Decrease) in Other Operating Assets and Liabilities, Net | (3,008) | 4,135 |
Net Cash Provided by (Used in) Investing Activities | ||
Payments for (Proceeds from) Short-term Investments | (1,060) | 1,049 |
Proceeds from (Payments for) Securities Purchased under Agreements to Resell | (139,647) | 5,740 |
Proceeds from Sale of Debt and Equity Securities, FV-NI, Held-for-investment | 3,494 | 0 |
Proceeds from Sale of Debt Securities, Available-for-sale | 10,366 | 36,413 |
Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale | 44,520 | 55,936 |
Payments to Acquire Debt Securities, Available-for-sale | 8,343 | 96,353 |
Cash Divested from Deconsolidation | 4,878 | 0 |
Payments to Acquire Businesses, Net of Cash Acquired | 0 | 13,707 |
Payments to Acquire Other Investments | 2,500 | 1,250 |
Other investing activities | 1,870 | 3,372 |
Net Cash Provided by (Used in) Investing Activities | (97,798) | (17,642) |
Net Cash Provided by (Used in) Financing Activities | ||
Payments for Repurchase of Common Stock | 140 | 4,489 |
Net Change Annuities and Investment Certificates | (112) | (326) |
Payments of Ordinary Dividends, Common Stock | 3,221 | 6,215 |
Proceeds from (Payments for) Other Financing Activities | (32) | (3) |
Net Cash Provided by (Used in) Financing Activities | (3,505) | (11,033) |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations, Beginning Balance | 74,793 | 24,631 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations, Ending Balance | 27,025 | 24,203 |
Noncash or Part Noncash Divestiture, Amount of Consideration Received | $ 78,779 | $ 0 |
Organization, Consolidation, Ba
Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block] | 6 Months Ended |
Jun. 30, 2021 | |
Notes | |
Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies | Note 1. Organization, Consolidation, Basis of Presentation and Accounting Policies (A) Business and Organization (B) Basis of Presentation The unaudited Condensed Consolidated Financial Statements have been prepared in conformity with U.S. generally accepted accounting principles ("GAAP") for interim financial statements and with the instructions to Form 10-Q and Article 10 of Regulation S-X and, therefore, do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. The unaudited Condensed Consolidated Financial Statements include the accounts of IHC and its consolidated subsidiaries. All significant intercompany transactions have been eliminated in consolidation. The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect: (i) the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements; and (ii) the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. IHC’s Annual Report on Form 10-K as filed with the Securities and Exchange Commission should be read in conjunction with the accompanying unaudited Condensed Consolidated Financial Statements. During the second quarter of 2021, the Board of Directors committed to various plans for the disposal of several business operations (see Note 2). Each plan represents a strategic shift that will have a major effect on the Company’s operations and financial results and as such, they each qualify for reporting as discontinued operations in the second quarter 2021. The assets, liabilities, and related income and expenses associated with each disposal group are presented as discontinued operations in the accompanying condensed consolidated financial statements and Notes thereto for all periods presented. In March 2020, the World Health Organization declared the outbreak of COVID-19 a global health pandemic and the United States declared a national health emergency. COVID-19 has led to largescale disruption in the global economy, market instability and widespread unemployment in the United States. The COVID-19 outbreak continues to be a fluid situation and as it evolves, the duration of COVID-19 and its potential effects on our business cannot be certain. Regulatory mandates have affected, and we anticipate will continue to impact, the insurance industry. We currently cannot predict if there will be a material impact to our business, results of operations or financial condition in future reporting periods. Consequently, future changes in market conditions may impact estimates used in the preparation of our financial statements associated with evaluations of goodwill and other intangible assets for impairment, estimates associated with the determination of valuation allowances related to net operating loss carryforwards, and estimates of certain losses under insurance contracts. These estimates may all be subject to substantial adjustments in future periods. In addition, volatile market conditions may result in declines in the fair value of our investment portfolio and possible impairments of certain securities. In the opinion of management, all adjustments (consisting only of normal recurring accruals) that are necessary for a fair presentation of the consolidated financial position and results of operations for the interim periods have been included. The condensed consolidated results of operations for the three months and six months ended June 30, 2021 are not necessarily indicative of the results to be anticipated for the entire year. (C) Reclassifications Certain amounts in prior year’s condensed consolidated financial statements and Notes thereto have been reclassified to conform to the 2021 presentation, primarily for the effects of discontinued operations. (D) Recent Accounting Pronouncements Recently Adopted Accounting Standards In December 2019, the Financial Accounting Standard Board (“FASB”) issued guidance to simplify the accounting for income taxes. The guidance eliminates certain exceptions related to the approach for intra-period tax allocation, the methodology for calculating income taxes in an interim period, and the recognition of deferred tax liabilities related to changes in ownership of equity method investments and foreign subsidiaries. The guidance also simplifies aspects of accounting for franchise taxes, the requirement to allocate current and deferred tax expense to legal entities not subject to tax in its separate financial statements, enacted changes in tax laws or rates, and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. The adoption of this guidance did not have a material effect on the Company’s consolidated financial statements. Recently Issued Accounting Standards Not Yet Adopted In August 2018, the FASB issued guidance to improve existing measurements, presentation and disclosure requirements for long-duration contracts issued by insurance entities. The amendments in this guidance requires an entity to (1) review and update assumptions used to measure cash flows at least annually as well as update the discount rate assumption at each reporting date; (2) measure market risk benefits associated with deposit contracts at fair value; (3) disclose liability rollforwards and information about significant inputs, judgements assumptions, and methods used in measurement. Additionally, it simplifies the amortization of deferred acquisition costs and other balances on a constant level basis over the expected term of the related contracts. In 2019, the FASB delayed the original effective dates. For smaller reporting companies, the amendments in this guidance are now effective for fiscal years beginning after December 15, 2023, and for interim periods within fiscal years beginning after December 15, 2024. Upon adoption, the amendments in this guidance should be applied to contracts in-force as of the beginning of the earliest period presented with a cumulative adjustment to beginning retained earnings. Management is evaluating the requirements and potential impact that the adoption of this guidance will have on the Company’s consolidated financial statements. In June 2016, the FASB issued guidance requiring financial assets measured at amortized cost basis to be presented at the net amount expected to be collected. An allowance for credit losses will be deducted from the amortized cost basis to present the net carrying value at the amount expected to be collected with changes in the allowance recorded in earnings. Credit losses relating to available-for-sale debt securities will also be recorded through an allowance for credit losses rather than the currently applied U.S. GAAP method of taking a permanent impairment of the security, which would be limited to the amount by which fair value is below the amortized cost. Certain existing requirements used to evaluate credit losses have been removed. In 2019, the FASB provided transition relief by providing entities with an option to irrevocably elect the fair value option on an instrument-by-instrument basis for eligible instruments upon adoption and delayed the original effective dates. For smaller reporting companies, the amendments in this guidance are now effective for fiscal years beginning after December 15, 2022, including interim periods within those years. Early adoption is permitted. The amendments in this guidance should be applied through a cumulative effect adjustment to retained earnings upon adoption as of the beginning of the first reporting period in which the guidance is effective. Management is evaluating the requirements and potential impact that the adoption of this guidance will have on the Company’s consolidated financial statements. |
Disposal Groups, Including Disc
Disposal Groups, Including Discontinued Operations, Disclosure | 6 Months Ended |
Jun. 30, 2021 | |
Notes | |
Disposal Groups, Including Discontinued Operations, Disclosure | Note 2. Discontinued Operations (A) Sale of Standard Security Life On April 14, 2021, IHC and its wholly owned subsidiary, Independence Capital Corp. (“ICC”), entered into a Stock Purchase Agreement (the “SSL Purchase Agreement”) with Reliance Standard Life Insurance Company (“Reliance Standard”) to sell all of the issued and outstanding capital stock of Standard Security Life, a wholly owned subsidiary of ICC, for an aggregate purchase price of $180,000,000 in cash. In addition, at closing, the Company will receive a dividend from Standard Security Life equal to the excess of aggregate statutory capital and surplus over $53,000,000 as of the closing date. Standard Security Life had statutory capital and surplus of $82,091,000 at June 30, 2021. The closing of the transaction, the closing dividend and certain other items are subject to customary closing conditions including applicable regulatory approvals, one of which is the approval of the New York State Department of Financial Services. Standard Security Life currently cedes a portion of its New York short-term disability (“DBL”) and paid family leave rider (“PFL”) business to Independence American Insurance Company. We filed notice to cancel this reinsurance contract in accordance with the terms of the SSL Purchase Agreement. Under the terms of the SSL Purchase Agreement, the sale transaction will include all of Standard Security Life’s DBL and PFL business (including the DBL and PFL business previously ceded to Independence American Insurance Company) and will exclude other lines of business which will be reinsured prior to the closing. The DBL and PFL business being sold was part of the Company’s Group disability, life, DBL and PFL segment. The aforementioned transaction, consisting of the sale of Standard Security Life, the closing dividend and other closing conditions, is collectively referred to as the “SSL Sale” transaction or disposal group. DBL and PFL are major product lines for the Company. The sale of Standard Security Life and resulting exit from DBL and PFL business represents a strategic shift that will have a major effect on the Company’s operations and financial results. The SSL Sale transaction qualified for reporting as discontinued operations in the second quarter of 2021 upon the Board of Director’s commitment to a plan for its disposal in April 2021, and the subsequent execution of the SSL Purchase Agreement. Provided that all regulatory approvals and other closing conditions are met, the Company expects to complete the SSL Sale transaction by the end of 2021. On July 29, 2021, the SSL Purchase Agreement was amended and restated to: (i) include in the disposal group, the business lines that were previously excluded from the transaction; (ii) remove the reinsurance requirement for the previously excluded business lines; and (iii) increase the target statutory capital and surplus to $57,000,000. As a result of this change in the disposal plan, the Company will include the assets, liabilities and results of operations for those business lines affected in discontinued operations for all periods presented, beginning in the third quarter of 2021. Aside from customary transition services, there will be no continuing involvement with Standard Security Life after its disposal. (B) Sale of Pet Division and Independence American Insurance Company (“Pets Sale”) On May 17, 2021, IHC and certain subsidiaries entered into agreements to sell a 70% controlling interest in its pet division, including all of the issued and outstanding capital stock of Independence American Insurance Company to a subsidiary of Iguana Capital, Inc. (“Iguana Capital”), an investment company specifically formed to facilitate this transaction as follows: (i) (ii) (iii) Both agreements are subject to customary closing conditions. The closing of the IAHC Purchase Agreement however is also subject to certain regulatory approvals, one of which is the approval of the Delaware Insurance Department. For this reason, the transaction was structured as two agreements such that the sale of PetPartners occurred on June 30, 2021, and the closing of the transactions contemplated in the IAHC Purchase Agreement will follow at a later date upon receipt of applicable regulatory approvals. Provided that all regulatory approvals and other closing conditions are met, the Company expects to complete the IAHC sale transaction by the end of 2021. Under the terms of the IAHC Purchase Agreement, the transaction includes the sale of all Independence American Insurance Company’s pet business and excludes other business lines. These excluded business lines will be retained by the Company through a reinsurance agreement with Madison National Life prior to closing. The reinsurance agreement will remain in effect until the underlying business is either transferred to Madison National Life or the business runs out. The aforementioned transaction, consisting of the sale of PetPartners, IAHC and Independence American Insurance Company, and other closing conditions, is collectively referred to as the “Pets Sale” transaction or disposal group. The pet business being sold was part of the Company’s Specialty Health segment. Because the pet business is a major product line for the Company, and the Company will no longer actively engage in the sales and marketing of pet insurance, the Pets Sale transaction represents a strategic shift that will have a major effect on the Company’s operations and financial results. The Pets Sale transaction qualified for reporting as discontinued operations in the second quarter of 2021 as a result of the Board of Directors’ commitment to a plan for the disposal of a controlling interest in its pet business in May 2021, and the execution of both the PPI Purchase Agreement and the IAHC Purchase Agreement on May 17, 2021. On June 30, 2021, the Company completed the sale of its majority interest in PetPartners and, as a result, the Company ceased to have a controlling financial interest in PetPartners. Upon closing, the Company received proceeds of $78,779,000 (consisting of the purchase price and certain initial working capital adjustments), recognized an initial equity investment in Iguana Capital valued at $33,762,000, and recorded a $62,693,000 gain on the disposal, net of transaction costs and income taxes. Transaction costs consisting of transaction bonuses, legal expenses and financial advisor expenses amounted to an aggregate of $6,070,000. The PPI Purchase Agreement includes a waiver and consent to offer The American Kennel Club (“AKC”), PetPartners’ minority shareholder, until December 31, 2021, the right to sell their shares at the same price and terms as in the PPI Purchase Agreement. In the event AKC desires to sell such its shares, Iguana Capital and SBH will equally finance the cash payment to AKC. In connection with the PPI Sale transaction, the Company recorded a $6,800,000 contingent liability (the maximum amount required) based on its belief that AKC will exercise this right. If for any reason the IAHC Purchase Agreement is terminated, then at the option of either SBH or an affiliate of Iguana Capital, IAHC may reacquire the Company’s interest in PetPartners (the “PPI Put/Call Option”). The value of the PPI Put/Call Option was deemed to be negligible due to the structure of the put and call features, the short time horizon and the Company’s belief that there is a low probability that the deal would be terminated. The proceeds received from the sale of PetPartners were deposited into an escrow account owned by SBH and treated as a security deposit. The funds will be released from escrow upon either the consummation of the IAHC sale transaction or upon the exercise of the PPI Put/Call Option. At June 30, 2021, the security deposit is presented as funds held in escrow on the Condensed Consolidated Balance Sheet. Continuing involvement with the Pets Sale disposal group will consist of customary transition services, the reinsurance of retained business lines, the PPI Put/Call Option, and the equity investment in Iguana Capital. The following is a reconciliation, by disposal group, of the carrying amounts of major classes of assets and liabilities included in discontinued operations on the Condensed Consolidated Balance Sheets for the periods indicated (in thousands): June 30, 2021 SSL Sale Pets Sale Total Major classes of assets: Investments and cash $ 164,346 $ 144,688 $ 309,034 Goodwill - 41,716 41,716 Other assets 30,020 35,392 65,412 Assets attributable to discontinued operations $ 194,366 $ 221,796 $ 416,162 Major classes of liabilities: Policy benefits and claims $ 56,987 $ 12,743 $ 69,730 Unearned premiums 26,778 6,080 32,858 Other liabilities 12,500 5,092 17,592 Liabilities attributable to discontinued operations $ 96,265 $ 23,915 $ 120,180 December 31, 2020 SSL Sale Pets Sale Total Major classes of assets included in discontinued operations: Investments and cash $ 114,916 $ 149,844 $ 264,760 Goodwill - 62,414 62,414 Other assets 18,787 29,730 48,517 Assets attributable to discontinued operations $ 133,703 $ 241,988 $ 375,691 Major classes of liabilities included in discontinued operations: Policy benefits and claims $ 34,500 $ 11,775 $ 46,275 Unearned premiums 5,208 5,629 10,837 Other liabilities 9,316 9,511 18,827 Liabilities attributable to discontinued operations $ 49,024 $ 26,915 $ 75,939 The following is a reconciliation, by disposal group, of the major line items constituting the pretax profit of discontinued operations to the income from discontinued operations, net of tax, as shown on the Condensed Consolidated Statements of Income for the periods indicated (in thousands): For the Three Months Ended June 30, 2021 SSL Sale Pets Sale Total Revenues $ 50,342 $ 33,080 $ 83,422 Expenses: Insurance benefits, claims and reserves 24,341 18,442 42,783 Selling, general and administrative expenses 7,394 14,592 21,986 Pretax income of discontinued operations during phase-out 18,607 46 18,653 Pretax provision for loss on disposal (402) (410) (812) Pretax gain on disposal of discontinued operations - 74,534 74,534 Total pretax income from discontinued operations 18,205 74,170 92,375 Income tax expense on discontinued operations 3,836 11,734 15,570 Income from discontinued operations, net of tax $ 14,369 $ 62,436 $ 76,805 For the Three Months Ended June 30, 2020 SSL Sale Pets Sale Total Revenues $ 30,442 $ 20,407 $ 50,849 Expenses: Insurance benefits, claims and reserves 22,152 11,098 33,250 Selling, general and administrative expenses 6,150 7,855 14,005 Pretax income of discontinued operations during phase-out 2,140 1,454 3,594 Pretax provision for loss on disposal - - - Pretax gain on disposal of discontinued operations - - - Total pretax income from discontinued operations 2,140 1,454 3,594 Income tax expense on discontinued operations 822 442 1,264 Income from discontinued operations, net of tax $ 1,318 $ 1,012 $ 2,330 For the Six Months Ended June 30, 2021 SSL Sale Pets Sale Total Revenues $ 93,738 $ 61,999 $ 155,737 Expenses: Insurance benefits, claims and reserves 53,865 34,374 88,239 Selling, general and administrative expenses 14,850 26,796 41,646 Pretax income of discontinued operations during phase-out 25,023 829 25,852 Pretax provision for loss on disposal (402) (410) (812) Pretax gain on disposal of discontinued operations - 74,534 74,534 Total pretax income from discontinued operations 24,621 74,953 99,574 Income tax expense on discontinued operations 5,151 11,875 17,026 Income from discontinued operations, net of tax $ 19,470 $ 63,078 $ 82,548 For the Six Months Ended June 30, 2020 SSL Sale Pets Sale Total Revenue $ 59,943 $ 37,838 $ 97,781 Expenses: Insurance benefits, claims and reserves 40,560 20,459 61,019 Selling, general and administrative expenses 13,004 14,515 27,519 Pretax income of discontinued operations during phase-out 6,379 2,864 9,243 Pretax provision for loss on disposal - - - Pretax gain on disposal of discontinued operations - - - Total pretax income from discontinued operations 6,379 2,864 9,243 Income tax expense on discontinued operations 1,689 741 2,430 Income from discontinued operations, net of tax $ 4,690 $ 2,123 $ 6,813 The assets and liabilities in discontinued operations are measured at the lower of their carry value or fair value less cost to sell. During the three months and six months ended June 30, 2021, it was not necessary to write-down any assets or liabilities attributable to the disposal groups in discontinued operations to fair value, less costs to sell. The Company expects to recognize gains from the sales of these disposal groups, therefore, any costs to sell the disposal groups, primarily legal expenses, incurred prior to the actual disposal of the discontinued operation, are expensed when incurred and presented in pretax provision for loss on disposal in the tables above. Pretax income (loss) from discontinued operations during phase-out attributable to IHC was $18,653,000 and $25,852,000 for the three and six months ended June 30, 2021, respectively, and was $3,594,000 and $9,243,000 for the three and six months ended June 30, 2020, respectively. Total cash flows from operating activities of discontinued operations were $45,917,000 and $26,813,000 for the six months ended June 30, 2021 and 2020, respectively. Total cash flows from investing activities of discontinued operations were $(88,501,000) and $(29,753,000) for the six months ended June 30, 2021 and 2020, respectively. On a consolidated basis, the Company recorded $15,570,000 and $1,264,000 of income taxes related to pretax income from discontinued operations for the three months ended June 30, 2021 and 2020, respectively, and $17,026,000 and $2,430,000 for the six months ended June 30, 2021 and 2020, respectively. In 2021, these amounts include $11,841,000 of income taxes related to the pretax gain on disposal of discontinued operations. In connection with the sale of PetPartners, AMIC decreased its valuation allowance on existing deferred tax assets by $8,281,000 and utilized approximately $46,116,000 of its outstanding Federal net operating loss carryforwards (See Note 11). Differences between the Federal statutory income tax rate on discontinued operations and the Company’s effective income tax rate on pretax income from discontinued operations are primarily the result of AMIC’s decrease in its valuation allowance, state and local income taxes, nondeductible goodwill and other expenses. |
Earnings Per Share _Text Block_
Earnings Per Share [Text Block] | 6 Months Ended |
Jun. 30, 2021 | |
Notes | |
Earnings Per Share | Note 3. Income Per Common Share Diluted income per share was computed using the treasury stock method. As a result of losses from continuing operations for the three months and six months ended June 30, 2021 and 2020, such shares were deemed anti-dilutive. The following is a reconciliation of income available to common shareholders used to calculate income per share for the periods indicated (in thousands): Three Months Ended Six Months Ended June 30, June 30, 2021 2020 2021 2020 Income from continuing operations attributable to IHC $ (436) $ (1,835) $ (612) $ (1,987) Income from discontinued operations attributable to IHC $ 76,907 $ 2,256 $ 82,704 $ 6,686 Net income attributable to IHC $ 76,471 $ 421 $ 82,092 $ 4,699 |
Cash and Cash Equivalents Discl
Cash and Cash Equivalents Disclosure | 6 Months Ended |
Jun. 30, 2021 | |
Notes | |
Cash and Cash Equivalents Disclosure | Note 4. Cash, Cash Equivalents and Restricted Cash June 30, 2021 2020 Cash and cash equivalents $ 22,834 $ 11,655 Restricted cash in other assets 418 985 Cash, cash equivalents and restricted cash in discontinued operations 3,773 11,563 Total cash, cash equivalents and restricted cash including discontinued operations $ 27,025 $ 24,203 Restricted cash includes insurance premiums collected from insureds that are pending remittance to insurance carriers and/or payment of insurance claims and commissions to third party administrators. These amounts are required to be set aside by contractual agreements with the insurance carriers and are included in other assets on the Condensed Consolidated Balance Sheets. |
Investments in Debt and Marketa
Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block] | 6 Months Ended |
Jun. 30, 2021 | |
Notes | |
Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure | Note 5. Investment Securities The cost (amortized cost with respect to certain fixed maturities), gross unrealized gains, gross unrealized losses and fair value of fixed maturities available-for-sale are as follows for the periods indicated (in thousands): June 30, 2021 GROSS GROSS AMORTIZED UNREALIZED UNREALIZED FAIR COST GAINS LOSSES VALUE FIXED MATURITIES AVAILABLE-FOR-SALE: Corporate securities $ 75,245 $ 1,583 $ (779) $ 76,049 CMOs – residential (1) 3,071 118 (5) 3,184 U.S. Government obligations 23,029 273 - 23,302 Agency MBS - residential (2) 35 - (4) 31 GSEs (3) 2,969 - (84) 2,885 States and political subdivisions 74,086 1,261 (384) 74,963 Foreign government obligations 3,144 151 - 3,295 Total fixed maturities $ 181,579 $ 3,386 $ (1,256) $ 183,709 December 31, 2020 GROSS GROSS AMORTIZED UNREALIZED UNREALIZED FAIR COST GAINS LOSSES VALUE FIXED MATURITIES AVAILABLE-FOR-SALE: Corporate securities $ 91,802 $ 2,174 $ (1,302) $ 92,674 CMOs – residential (1) 3,439 146 (2) 3,583 U.S. Government obligations 23,397 414 - 23,811 Agency MBS - residential (2) 39 - (5) 34 GSEs (3) 3,055 - (81) 2,974 States and political subdivisions 82,910 1,768 (452) 84,226 Foreign government obligations 3,211 206 - 3,417 Total fixed maturities $ 207,853 $ 4,708 $ (1,842) $ 210,719 (1) (2) (3) The amortized cost and fair value of fixed maturities available-for-sale at June 30, 2021, by contractual maturity, are shown below (in thousands). Expected maturities will differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties. AMORTIZED FAIR COST VALUE Due in one year or less $ 36,481 $ 36,938 Due after one year through five years 87,377 89,128 Due after five years through ten years 20,124 20,292 Due after ten years 31,522 31,252 Fixed maturities with no single maturity date 6,075 6,099 $ 181,579 $ 183,709 The following tables summarize, for all fixed maturities available-for-sale in an unrealized loss position, the aggregate fair value and gross unrealized loss by length of time those securities that have continuously been in an unrealized loss position for the periods indicated (in thousands): June 30, 2021 Less than 12 Months 12 Months or Longer Total Fair Unrealized Fair Unrealized Fair Unrealized Value Losses Value Losses Value Losses Corporate securities $ 19,962 $ 740 $ 4,503 $ 39 $ 24,465 $ 779 CMOs-residential 707 5 - - 707 5 Agency MBS - residential 31 4 - - 31 4 GSEs - 2,886 84 2,886 84 States and political subdivisions 10,319 76 8,813 308 19,132 384 Fixed maturities in an unrealized loss position $ 31,019 $ 825 $ 16,202 $ 431 $ 47,221 $ 1,256 Number of fixed maturities in an unrealized loss position 9 14 23 December 31, 2020 Less than 12 Months 12 Months or Longer Total Fair Unrealized Fair Unrealized Fair Unrealized Value Losses Value Losses Value Losses Corporate securities $ 23,591 $ 458 $ 8,845 $ 844 $ 32,436 $ 1,302 CMOs-residential 748 2 - - 748 2 Agency MBS - residential 34 5 - - 34 5 GSEs - - 2,974 81 2,974 81 States and political subdivisions 16,983 150 6,108 302 23,091 452 Fixed maturities in an unrealized loss position $ 41,356 $ 615 $ 17,927 $ 1,227 $ 59,283 $ 1,842 Number of fixed maturities in an unrealized loss position 20 13 33 Substantially all of the unrealized losses on fixed maturities available-for-sale at June 30, 2021 and December 31, 2020 relate to investment grade securities. Management does not intend to sell, and it is likely that management will not be required to sell these securities prior to their anticipated recovery. The unrealized losses on the Company's fixed maturity securities are related to general market changes in interest rates, and/or the levels of credit spreads largely due to current market conditions relating to the COVID-19 pandemic rather than specific concerns with the issuer's ability to pay interest and repay principal. We have evaluated each corporate security’s credit rating as well as industry risk factors associated with the securities. The fair value of these securities is expected to recover as they approach maturity and therefore the Company does not consider these investments to be other-than-temporarily impaired at June 30, 2021. Net investment gains are as follows for periods indicated (in thousands): Three Months Ended Six Months Ended June 30, June 30, 2021 2020 2021 2020 Realized gains (losses): Fixed maturities available-for-sale $ (126) $ 50 $ 46 $ 284 Equity securities - - 292 - Total realized gains (losses) on debt and equity securities (126) 50 338 284 Unrealized gains (losses) on equity securities - 214 (247) (184) Gains (losses) on debt and equity securities (126) 264 91 100 Gains (losses) on other investments - 10 - 17 Net investment gains $ (126) $ 274 $ 91 $ 117 For the three months and six months ended June 30, 2021, the Company realized gross gains of $61,000 and $254,000, respectively, and gross losses of $187,000 and $206,000, respectively, from sales, maturities and prepayments of fixed maturities available-for-sale. For the three months and six months ended June 30, 2020, the Company realized gross gains of $97,000 and $346,000, respectively, and gross losses of $47,000 and $62,000, respectively, from sales, maturities and prepayments of fixed maturities available-for-sale. Other-Than-Temporary Impairment Evaluations We recognize other-than-temporary impairment losses in earnings in the period that we determine: 1) we intend to sell the security; 2) it is more likely than not that we will be required to sell the security before recovery of its amortized cost basis; or 3) the security has a credit loss. Any non-credit portion of the other-than-temporary impairment loss is recognized in other comprehensive income (loss). See Note 1G(v) to the Consolidated Financial Statements in the 2020 Annual Report on Form 10-K for further discussion of the factors considered by management in its regular review to identify and recognize other-than-temporary impairments on fixed maturities available-for-sale. The Company did not recognize any other-than-temporary impairments on available-for-sale securities in the first six months of 2021 or 2020. |
Fair Value Disclosures _Text Bl
Fair Value Disclosures [Text Block] | 6 Months Ended |
Jun. 30, 2021 | |
Notes | |
Fair Value Disclosures | Note 6. Fair Value Disclosures For all financial and non-financial assets and liabilities accounted for at fair value on a recurring basis, the Company utilizes valuation techniques based upon observable and unobservable inputs. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect our market expectations. These two types of inputs create the following fair value hierarchy: Level 1 Level 2 Level 3 The following section describes the valuation methodologies we use to measure different assets at fair value. Fixed maturities available-for-sale: Fixed maturities available-for-sale included in Level 2 are comprised of our portfolio of government securities, agency mortgage-backed securities, corporate fixed income securities, foreign government obligations, collateralized mortgage obligations, municipals and GSEs that were priced with observable market inputs. Level 3 debt securities consist of municipal tax credit strips. The valuation method used to determine the fair value of municipal tax credit strips is the present value of the remaining future tax credits (at the original issue discount rate) as presented in the redemption tables in the Municipal Prospectuses. This original issue discount is accreted into income on a constant yield basis over the term of the debt instrument. Further, we retain independent pricing vendors to assist in valuing certain instruments. Equity securities: The following tables present our financial assets measured at fair value on a recurring basis for the periods indicated (in thousands): June 30, 2021 Level 1 Level 2 Level 3 Total FINANCIAL ASSETS: Fixed maturities available-for-sale: Corporate securities $ - $ 76,049 $ - $ 76,049 CMOs - residential - 3,184 - 3,184 US Government obligations - 23,302 - 23,302 Agency MBS - residential - 31 - 31 GSEs - 2,885 - 2,885 States and political subdivisions - 73,949 1,014 74,963 Foreign government obligations - 3,295 - 3,295 Total fixed maturities - 182,695 1,014 183,709 Total Financial Assets $ - $ 182,695 $ 1,014 $ 183,709 December 31, 2020 Level 1 Level 2 Level 3 Total FINANCIAL ASSETS: Fixed maturities available-for-sale: Corporate securities $ - $ 92,674 $ - $ 92,674 CMOs - residential - 3,583 - 3,583 US Government obligations - 23,811 - 23,811 Agency MBS - residential - 34 - 34 GSEs - 2,974 - 2,974 States and political subdivisions - 83,130 1,096 84,226 Foreign government obligations - 3,417 - 3,417 Total fixed maturities - 209,623 1,096 210,719 Equity securities: Common stocks 1,753 - - 1,753 Total equity securities 1,753 - - 1,753 Total Financial Assets $ 1,753 $ 209,623 $ 1,096 $ 212,472 The following table presents the changes in fair value of our Level 3 financial assets for the periods indicated (in thousands): Three Months Ended June 30, 2021 2020 States and Total States and Total Political Level 3 Political Level 3 Subdivisions Assets Subdivisions Assets Beginning b alance $ 1,055 $ 1,055 $ 1,214 $ 1,214 Increases (decreases) recognized in earnings: Net investment gains - - - - Gains (losses) included in other comprehensive income (loss): Net unrealized gains (losses) (4) (4) (5) (5) Repayments and amortization of fixed maturities (37) (37) (34) (34) Balance at end of period $ 1,014 $ 1,014 $ 1,175 $ 1,175 Six Months Ended June 30, 2021 2020 States and Total States and Total Political Level 3 Political Level 3 Subdivisions Assets Subdivisions Assets Beginning b alance $ 1,096 $ 1,096 $ 1,251 $ 1,251 Increases (decreases) recognized in earnings: Net investment gains - - - - Gains (losses) included in other comprehensive income (loss): Net unrealized gains (losses) (8) (8) (9) (9) Repayments and amortization of fixed maturities (74) (74) (67) (67) Balance at end of period $ 1,014 $ 1,014 $ 1,175 $ 1,175 Included in unrealized gains (losses) on available-for-sale securities, pre-tax, on the Condensed Consolidated Statement of Comprehensive Income for the three months and six months ended June 30, 2021 are $(4,000) and $(8,000) of unrealized gains (losses) attributable to the change in unrealized gains (losses) related to Level 3 securities held at June 30, 2021. The following table provides carrying values, fair values and classification in the fair value hierarchy of the Company’s financial instruments, that are not carried at fair value but are subject to fair value disclosure requirements, for the periods indicated (in thousands): June 30, 2021 December 31, 2020 Level 1 Level 2 Level 1 Level 2 Fair Fair Carrying Fair Fair Carrying Value Value Value Value Value Value FINANCIAL ASSETS: Short-term investments $ 1,550 $ - $ 1,550 $ 1,568 $ - $ 1,568 Securities purchased under agreements to resell 70,323 - 70,323 33,038 - 33,038 FINANCIAL LIABILITIES: Funds on deposit $ - $ 142,155 $ 142,155 $ - $ 141,376 $ 141,376 Other policyholders’ funds - 11,988 11,988 - 12,001 12,001 The following methods and assumptions were used to estimate the fair value of the financial instruments that are not carried at fair value in the Condensed Consolidated Financial Statements: Securities purchased under agreements to resell Securities purchased under agreements to resell are carried at the amounts at which the securities will be subsequently resold, which approximates fair value. Short-term Investments Investments with original maturities of 91 days to one year are considered short-term investments and are carried at cost, which approximates fair value. Funds on Deposit The Company has two types of funds on deposit. The first type is credited with a current market interest rate, resulting in a fair value which approximates the carrying amount. The second type carries fixed interest rates which are higher than current market interest rates. The fair value of these deposits was estimated by discounting the payments using current market interest rates. The Company's universal life policies are also credited with current market interest rates, resulting in a fair value which approximates the carrying amount. Both types of funds on deposit are included in Level 2 of the fair value hierarchy. Other Policyholders’ Funds Other policyholders’ funds are primarily credited with current market interest rates resulting in a fair value which approximates the carrying amount. |
Investments in and Advances to
Investments in and Advances to Affiliates, Schedule of Investments [Text Block] | 6 Months Ended |
Jun. 30, 2021 | |
Notes | |
Investments in and Advances to Affiliates, Schedule of Investments | Note 7. Other Investments, Including Variable Interest Entities Equity Method Investments Equity income (loss) from equity method investments for the three months and six months ended June 30, 2021 was $4,000 and $64,000 respectively; and was $(356,000) and $(28,000) for the three months and six months ended June 30, 2020, respectively. Variable Interest Entities The Company has a minority interest in certain limited partnerships that we have determined to be Variable Interest Entities (“VIEs”). The aforementioned VIEs are not required to be consolidated in the Company’s condensed consolidated financial statements as we are not the primary beneficiary since we do not have the power to direct the activities that most significantly impact the VIEs’ economic performance. The Company will periodically reassess whether we are the primary beneficiary in any of these investments. The reassessment process will consider whether we have acquired the power to direct the most significant activities of the VIE through changes in governing documents or other circumstances. Our maximum loss exposure is limited to our combined $2,022,000 carrying value in these equity investments which is included in other investments in the Condensed Consolidated Balance Sheet as of June 30, 2021. Related Party Transactions At June 30, 2021 and December 31, 2020, the Company’s Condensed Consolidated Balance Sheets include $94,000 and $163,000, respectively, of administrative fees and other expenses payable to Ebix Health Exchange Holdings, LLC (“Ebix Health Exchange”), which are included in other assets and accounts payable, accruals and other liabilities, respectively. The Company’s Condensed Consolidated Statements of Income include administrative fee expenses to Ebix Health Exchange, which are included in selling, general and administrative expenses, of $361,000 and $762,000, respectively, for the three months and six months ended June 30, 2021; and include $423,000 and $899,000, respectively, for the same periods in 2020. |
Business Combination Disclosure
Business Combination Disclosure | 6 Months Ended |
Jun. 30, 2021 | |
Notes | |
Business Combination Disclosure | Note 8. Acquisitions The Abacus Group, LLC . On January 1, 2020 (the "Abacus Acquisition Date"), the Company acquired the remaining 56% membership units of The Abacus Group, LLC, (“Abacus”) for a purchase price of $2,599,000, Abacus is an agency group that writes worksite business for Madison National Life and other carriers and receives commissions and other fees. The Company acquired Abacus to further the Company’s position in the worksite marketplace. The Company accounted for its prior ownership interest using the equity method. Immediately preceding the transaction, the Company determined the fair value of its equity interest to be $1,838,000 using a market approach and, as a result, recorded a loss of $163,000, which is included in other income on the Condensed Consolidated Statement of Income. Upon the acquisition, the Company consolidated the assets and liabilities of Abacus. The following table presents the identifiable assets acquired and liabilities assumed in the acquisition of Abacus on the Abacus Acquisition Date based on their respective fair values (in thousands): Other assets $ 350 Total identifiable assets 350 Other liabilities 575 Total liabilities 575 Net identifiable assets (liabilities) acquired $ (225) In connection with the acquisition, the Company recorded $4,662,000 of goodwill of which $2,725,000 is deductible for income tax purposes. Goodwill represents the synergies with our insurance carriers. Abacus has an existing distribution network and offers increased distribution sources for IHC carriers’ existing products and developing products through its enrollment platform designed specifically for producers in the worksite marketplace. Goodwill was calculated as the sum of (i) the acquisition date fair value of total cash consideration transferred of $2,599,000, (ii) the aggregate acquisition-date fair value of equity interests immediately before the acquisition of $1,838,000, and (iii) the net identifiable liabilities of $225,000 that were assumed. The enterprise value of Abacus was determined by a market approach net of any control premium. Acquisition-related costs, primarily legal and consulting fees, were not material and are included in selling, general and administrative expenses in the Condensed Consolidated Statement of Income. Revenue and net income from Abacus for the period from the Abacus Acquisition Date to June 30, 2020, is not material as most of their agency fee income is derived from Madison National Life and is now eliminated in consolidation. The amount of fee income earned from other carriers in 2020 is not material and will reduce over time as the business either runs-off or is transitioned to Madison National Life. Pro forma adjustments to present the Company’s consolidated revenues and net income as if the acquisition date was January 1, 2019 are not material and accordingly are omitted. Torchlight Technology Group LLC. On April 15, 2020 (the "Torchlight Acquisition Date"), the Company acquired the remaining 77% membership units of Torchlight Technology Group LLC, (“Torchlight”) for a purchase price of $11,443,000 in cash and other consideration valued at $185,000. In accordance with the purchase and sale agreement, the Company will also make future incentive payments to the former owners based on the future market appreciation of IHC. These payments will be accounted for as compensation for post-combination services. The Company purchased Torchlight for its marketing technology (“MarTech”), artificial data intelligence, and consumer lead generation capabilities. In an effort to further expand our InsureTech division (comprised of Torchlight, our call centers, field and career agents, and web domains), the Company wants to be able to internally develop and deliver lead traffic opportunities in an affordable and controlled environment. The Company accounted for its prior ownership interest using the equity method. Immediately preceding the transaction, the Company determined the fair value of its equity interest to be $3,432,000 using the income approach and, as a result, recorded a gain of $519,000, which is included in other income on the Condensed Consolidated Statement of Income. Upon the acquisition, the Company consolidated the assets and liabilities of Torchlight. The following table presents the identifiable assets acquired and liabilities assumed in the acquisition of Torchlight on the Torchlight Acquisition Date based on their respective fair values (in thousands): Cash $ 333 Intangible assets 2,700 Other assets 2,132 Total identifiable assets 5,165 Other liabilities 1,227 Total liabilities 1,227 Net identifiable assets acquired $ 3,938 In connection with the acquisition, the Company recorded $11,122,000 of goodwill, of which $7,976,000 is deductible for income tax purposes, and $2,700,000 of intangible assets. In 2021, a portion of this goodwill was allocated to the Pets Sale disposal group presented in discontinued operations. Goodwill represents the synergies with our agencies. With a significant dependence on consumer and small business opportunities, our agencies require a consistent and predictable flow of lead traffic, and as a result, have meaningful synergies with the functions and deliverables that are developed at Torchlight. Before the acquisition of Torchlight, our agency was fully dependent on market traffic, which was both unpredictable in price and availability. Such restrictions would not allow for coordinated or scheduled growth. Goodwill was calculated as the sum of (i) the acquisition date fair value of total aggregate consideration transferred of $11,628,000; and (ii) the aggregate acquisition-date fair value of equity interests immediately before the acquisition of $3,432,000; over (iii) the net identifiable assets of $3,938,000 that were acquired. The enterprise value of Torchlight was determined by an independent appraisal using a discounted cash flow model. Acquisition-related costs, primarily legal and consulting fees, were not material and are included in selling, general and administrative expenses in the Condensed Consolidated Statement of Income. Revenue and net loss from Torchlight for the period from the Torchlight Acquisition Date to June 30, 2020 is $1,828,000 and $(564,000), respectively. The net loss is primarily related to the integration of Torchlight with the Company’s other operations. Pro forma adjustments to present the Company’s consolidated revenues and net income as if the acquisition date was January 1, 2019 are not material and accordingly are omitted. |
Goodwill and Intangible Assets
Goodwill and Intangible Assets Disclosure [Text Block] | 6 Months Ended |
Jun. 30, 2021 | |
Notes | |
Goodwill and Intangible Assets Disclosure | Note 9. Goodwill and Other Intangible Assets The carrying amount of goodwill is $12,486,000 at June 30, 2021 and December 31, 2020, of which $8,263,000 is attributable to the Specialty Health Segment at both June 30, 2021 and December 31, 2020, and $4,223,000 is attributable to the Group disability and life segment for the same periods. The Company has net other intangible assets of $3,667,000 and $4,008,000 at June 30, 2021 and December 31, 2020, respectively, which are included in other assets in the Condensed Consolidated Balance Sheets. These intangible assets consist of: (i) finite-lived intangible assets, principally the fair value of acquired agent and broker relationships, which are subject to amortization; and (ii) indefinite-lived intangible assets which consist of the estimated fair value of insurance licenses that are not subject to amortization. The gross carrying amounts of these other intangible assets are as follows for the periods indicated (in thousands): June 30, 2021 December 31, 2020 Gross Gross Carrying Accumulated Carrying Accumulated Amount Amortization Amount Amortization Finite-lived Intangible Assets: Agent and broker relationships $ 6,583 $ 4,599 $ 7,583 $ 5,385 Software systems 1,500 294 1,500 167 Total finite-lived $ 8,083 $ 4,893 $ 9,083 $ 5,552 June 30, December 31, 2021 2020 Indefinite-lived Intangible Assets: Insurance licenses $ 477 $ 477 Total indefinite-lived $ 477 $ 477 |
Revenue from Contract with Cust
Revenue from Contract with Customer | 6 Months Ended |
Jun. 30, 2021 | |
Notes | |
Revenue from Contract with Customer | Note 10. Fee Income Substantially all of the fee income recorded by the IHC Agencies and lead generation company relate to our Specialty Health segment. The following table presents fee income disaggregated by type for the periods indicated (in thousands). Three Months Ended Six Months Ended June 30, June 30, 2021 2020 2021 2020 Commissions $ 1,416 1,932 4,297 $ 3,672 Administrative Fees 80 581 177 1,069 Marketing Fees 254 292 559 643 Enrollment Platform Fees 529 455 1,029 973 Lead and Referral Fees 2,633 588 4,945 854 Payment Plan, Application and Other Fees 32 59 72 130 Total Fee Income $ 4,944 3,907 11,079 $ 7,341 Commission Revenues Commission revenues result from the sales of certain policies by the IHC Agencies on behalf of multiple unaffiliated insurance carriers. Increased sales of products to these unaffiliated insurance carriers began in 2020 as a result of new contracts with the carriers and increased distribution channels. These policies primarily consist of senior products, such as Medicare Advantage, Medicare Part D prescription drug plans and Medicare Supplement plans, as well as Affordable Care Act (“ACA”) plans. A significant portion of our commission revenues are recorded at a point in time upon the issuance of a policy by the unaffiliated insurance carrier based on expected constrained lifetime value (“LTV”). Constrained LTV represents expected commissions to be received over the lifetime of the policies sold. The Company analyzes various factors, such as commission rates, carrier mix, contract amendments and terminations, estimated average plan durations, cancellations and non-renewals, to estimate the LTV. Constraints are applied to help ensure that the total estimated lifetime commissions expected to be collected are recognized as revenue only to the extent that it is probable that a significant reversal in the amount of cumulative revenue recognized will not occur. We evaluate the appropriateness of our constraints on a quarterly basis and update the LTV assumptions if we observe evidence that suggests a change in the underlying long-term expectations. In doing this, we apply significant judgement in assessing historical cash collections and changes in circumstances that would impact future cash collections such as, but not limited to, commission rates, carrier mix, plan durations, plan cancellations and non-renewals. Changes in LTV result in an increase or decrease to fee income revenue and a corresponding increase or decrease to contract assets. Any significant impact due to changes in the LTV assumptions are recognized in revenue (i) in the period of the change; and (ii) to the extent we do not believe a significant reversal is probable. Costs to Fulfill a Contract Costs to fulfill a contract include commissions owed to independent licensed agents or affinity partners that are contracted by the IHC Agencies. Upon the submission of a completed insurance application, the sales and marketing performance obligation is complete and the resultant estimated lifetime commission costs incurred are expensed and a corresponding commission liability is recorded on the Condensed Consolidated Balance Sheet. As policyholders continue their policy and remit monthly premium payments, the Company receives its commissions from the insurance carrier. Commissions owed to the agent or affinity partner are then paid and the corresponding liability is reduced. Judgement is required to estimate total expected lifetime commissions based on policy duration assumptions. At June 30, 2021 and December 31, 2020, the aforementioned commission liability was $2,858,000 and $2,362,000, respectively, and is included in accounts payable, accruals and other liabilities on the Condensed Consolidated Balance Sheet. Contract Asset Contract assets primarily relate to our commission revenues for the sales of senior products, such as Medicare Advantage and Medicare Supplement plans and ACA plans, which began in 2020. When commission revenue for the sales of these products is recognized, a corresponding contract asset is recorded in other assets on the Condensed Consolidated Balance Sheet. The timing of revenue differs from the collection of commissions. As policyholders continue their policy and remit monthly premium payments, the Company receives its commissions from the insurance carrier and the contract asset is reduced. The following table summarizes the contract asset activity for the period indicated (in thousands). Six Months Ended June 30, 2021 Beginning Balance $ 7,760 Commissions recognized during the period 4,708 Commission adjustments related to prior periods (418) Cash receipts (3,251) Ending Balance $ 8,799 Remaining Performance Obligations Deferred revenues are recorded in connection with certain terminable contracts and the right to use our INSX enrollment platform. At June 30, 2021 and December 31, 2020, deferred revenues are immaterial and expected to be fully recognized within the next 12 months. |
Income Tax Disclosure _Text Blo
Income Tax Disclosure [Text Block] | 6 Months Ended |
Jun. 30, 2021 | |
Notes | |
Income Tax Disclosure | Note 11. Income Taxes The provisions for income taxes shown in the Condensed Consolidated Statements of Income were computed by applying the effective tax rate expected to be applicable for the reporting periods. Differences between the Federal statutory income tax rate and the Company’s effective income tax rate are principally from the dividends received deduction and tax-exempt interest income, state and local income taxes, and compensation related tax provisions. December 31, 2020, AMIC had Federal net operating loss carryforwards of approximately $46,116,000 and a corresponding valuation allowance of $8,281,000 related to those net operating loss carryforwards that, in the judgment of management, were not considered realizable. On June 30, 2021, the Company sold PetPartners and recorded a pretax gain of $74,534,000 (See Note 2). As a result, AMIC decreased its valuation allowance by $8,281,000 and utilized the $46,116,000 of its outstanding Federal net operating loss carryforwards. Total income tax expense related to the pretax gain on disposal of discontinued operations was $11,841,000. The primary differences between the Federal statutory income tax rate and the Company’s effective income tax rate related to the gain on disposal of discontinued operations are the result of AMIC’s decrease in its valuation allowance, partially offset by the non-deductibility of goodwill and other expenses related to the disposal. The effective income tax rates related to losses from continuing operations in 2021 were impacted by tax benefits from exercises of share-based compensation and state and local income tax benefits on certain subsidiaries. In 2020, the effective income tax rates related to losses from continuing operations reflect a benefit from capital losses attributable to the sale of a subsidiary, partially offset by certain non-deductible expenses recorded in connection with a Regulatory Settlement Agreement. On March 27, 2020, as part of the business stimulus package in response to the COVID-19 pandemic, the U.S. government enacted the Coronavirus Aid, Relief, and Economic Security ("CARES") Act. The CARES Act established new tax provisions including, but not limited to: (1) five-year carryback of net operating losses ("NOLs") generated in 2018, 2019 and 2020; (2) accelerated refund of alternative minimum tax (AMT) credit carryforwards; and (3) retroactive changes to allow accelerated depreciation for certain depreciable property. At this time, the legislation does not have a material impact on the Company due to the lack of taxable losses in the stated carryback eligible tax years and the fact that the Company was already expecting to receive a cash benefit for the remaining AMT credits in the fiscal 2018 tax year return. The New York State Department of Taxation and Finance has selected the Company’s 2015 and 2016 NYS returns for audit. |
Liability for Future Policy Ben
Liability for Future Policy Benefits and Unpaid Claims Disclosure [Text Block] | 6 Months Ended |
Jun. 30, 2021 | |
Notes | |
Liability for Future Policy Benefits and Unpaid Claims Disclosure | Note 12. Policy Benefits and Claims Policy benefits and claims is the liability for unpaid loss and loss adjustment expenses. It is comprised of unpaid claims and estimated incurred but not reported (“IBNR”) reserves. Summarized below are the changes in the total liability for policy benefits and claims for the periods indicated (in thousands). Amounts incurred below do not include expenses for policy benefits and costs incurred for the Company’s life, annuity and other long-duration contracts. In addition, certain loss adjustment expenses related to short-duration contracts that are included in amounts incurred below are classified as selling general and administrative expenses on the Condensed Consolidated Statements of Income. For the Six Months Ended June 30, 2021 Specialty Group All Other Health Disability Lines Total Balance at beginning of year $ 31,680 $ 80,976 $ 20,301 $ 132,957 Less: reinsurance recoverable 1,776 22,472 11,878 36,126 Net balance at beginning of year 29,904 58,504 8,423 96,831 Amount incurred, related to: Current year 16,631 20,031 11,947 48,609 Prior years (4,634) (4,033) (1,132) (9,799) Total incurred 11,997 15,998 10,815 38,810 Amount paid, related to: Current year 4,461 3,922 6,885 15,268 Prior years 12,080 11,488 3,667 27,235 Total paid 16,541 15,410 10,552 42,503 Net balance at end of period 25,360 59,092 8,686 93,138 Plus: reinsurance recoverable 1,161 22,492 11,024 34,677 Balance at end of period $ 26,521 $ 81,584 $ 19,710 $ 127,815 For the Six Months Ended June 30, 2020 Specialty Group All Other Health Disability Lines Total Balance at beginning of year $ 35,530 $ 80,079 $ 19,874 $ 135,483 Less: reinsurance recoverable 1,717 23,322 11,954 36,993 Net balance at beginning of year 33,813 56,757 7,920 98,490 Amount incurred, related to: Current year 24,522 19,093 11,182 54,797 Prior years (1,972) (1,553) (3,201) (6,726) Total incurred 22,550 17,540 7,981 48,071 Amount paid, related to: Current year 7,064 4,010 4,979 16,053 Prior years 17,530 12,125 2,155 31,810 Total paid 24,594 16,135 7,134 47,863 Net balance at end of period 31,769 58,162 8,767 98,698 Plus: reinsurance recoverable 1,802 22,463 11,074 35,339 Balance at end of period $ 33,571 $ 80,625 $ 19,841 $ 134,037 Since unpaid loss and loss adjustment expenses are estimates, actual losses incurred may be more or less than the Company’s previously developed estimates and is referred to as either unfavorable or favorable development, respectively. Net favorable (unfavorable) development in the Specialty Health segment, as depicted in the tables above, is comprised of the following lines of business for the years indicated (in thousands): Six Months Ended June 30, Specialty Health segment: 2021 2020 Short-term Medical (“STM”) $ 1,676 $ 286 Occupational Accident 963 798 Fixed Indemnity Limited Benefit 862 (736) Limited Medical 197 241 Critical Illness 196 397 Group Gap 356 513 All other specialty health lines 384 473 Total Specialty Health segment $ 4,634 $ 1,972 In both 2021 and 2020, net favorable development in the various lines of the Specialty Health segment shown above are primarily due to better than expected claim development. In 2021, experience in STM continues to be better than expected and severity has been relatively low. In 2021, favorable development of $4,033,000 in the group disability business is primarily due to lower frequency and severity in both the short-term disability (“STD”) and the long-term disability (“LTD”) lines. In 2020, favorable development in the group disability business is primarily due to a reduction in open claims, specifically new claims, in the LTD line, partially offset by an increase in the overall frequency and severity of claims in the STD line. All other lines, primarily life and other individual health products and including our medical stop-loss business in run-off, experienced favorable development in 2021 and 2020. The favorable development in 2020 is primarily related to the group term life business due to continued improvements in experience and updated assumptions for the Paid-Up Life business. Included in the preceding rollforward of the Company’s liability for policy benefits and claims are the policy benefits and claims activity associated with the Company’s health insurance lines. These are embedded within the Specialty Health segment. The table below summarizes the components of the change in the liability for policy benefits and claims that are specific to health insurance claims for the periods indicated (in thousands). Specialty Health Segment Health Insurance Claims Six Months Ended June 30, 2021 2020 Balance at beginning of year $ 28,295 $ 31,259 Less: reinsurance recoverable 1,766 1,113 Net balance at beginning of year 26,529 30,146 Amount incurred, related to: Current year 15,818 23,627 Prior years (3,658) (1,184) Total incurred 12,160 22,443 Amount paid, related to: Current year 4,319 8,260 Prior years 11,992 16,382 Total paid 16,311 24,642 Net balance at end of period 22,378 27,947 Plus: reinsurance recoverable 1,158 1,406 Balance at end of period $ 23,536 $ 29,353 The liability for the IBNR plus expected development on reported claims associated with the Company’s health insurance claims is $22,378,000 at June 30, 2021. |
Stockholders' Equity Note Discl
Stockholders' Equity Note Disclosure [Text Block] | 6 Months Ended |
Jun. 30, 2021 | |
Notes | |
Stockholders' Equity Note Disclosure | Note 13. Stockholders’ Equity Accumulated Other Comprehensive Income (Loss) Other comprehensive income (loss) includes the after-tax net unrealized gains and losses on investment securities available-for-sale, including the subsequent increases and decreases in fair value of available-for-sale securities previously impaired and the non-credit related component of other-than-temporary impairments of fixed maturities. Changes in the balances of accumulated other comprehensive income, shown net of taxes, for the periods indicated are as follows (in thousands): Three Months Ended Six Months Ended June 30, June 30, 2021 2020 2021 2020 Beginning balance $ 2,268 $ 1,101 $ 4,197 $ 1,212 Other comprehensive income (loss): Other comprehensive income (loss) before reclassifications 784 1,810 (1,013) 2,544 Amounts reclassified from accumulated OCI 168 (57) 36 (902) Net other comprehensive income (loss) 952 1,753 (977) 1,642 Ending balance $ 3,220 $ 2,854 $ 3,220 $ 2,854 Presented below are the amounts reclassified out of accumulated other comprehensive income (loss) and recognized in earnings for each of the periods indicated (in thousands): Three Months Ended Six Months Ended June 30, June 30, 2021 2020 2021 2020 Unrealized gains (losses) on available-for-sale securities reclassified during the period to the following income statement line items: Net investment gains (losses) $ (125) $ 47 $ 47 $ 284 Income (loss) from continuing operations before income taxes (125) 47 47 284 Income tax expense (benefit) (28) 10 9 60 Income (loss) from continuing operations, net of tax (97) 37 38 224 Total pretax income (loss) from discontinued operations (90) 25 (94) 858 Income tax expense (benefit) on discontinued operations (19) 5 (20) 180 Income from discontinued operations, net of tax (71) 20 (74) 678 Net income (loss) $ (168) $ 57 $ (36) $ 902 |
Cash Flow, Supplemental Disclos
Cash Flow, Supplemental Disclosures [Text Block] | 6 Months Ended |
Jun. 30, 2021 | |
Notes | |
Cash Flow, Supplemental Disclosures | Note 14. Supplemental Disclosures of Cash Flow Information Net cash payments for income taxes were $59,000 and $55,000 during the six months ended June 30, 2021 and 2020, respectively. |
Commitments and Contingencies D
Commitments and Contingencies Disclosure [Text Block] | 6 Months Ended |
Jun. 30, 2021 | |
Notes | |
Commitments and Contingencies Disclosure | Note 15. Contingencies Third Party Administrator A third party administrator with whom we formerly did business (“Plaintiff” or “TPA”) commenced an action on May 17, 2017 in the United States District Court, Northern District of Texas, Dallas Division (the “Texas Action”), naming IHC, Madison National Life, Standard Security Life, and Independence Brokerage Group, Inc. (formerly IHC Carrier Solutions, Inc.) as defendants (“Defendants”). The Plaintiff seeks contractual payments allegedly owed by the Defendants totaling at least $3,082,000 through 2014, plus additional amounts for 2015 and 2016, and exemplary and punitive damages as allowed by law and fees and costs. The court had previously stayed the proceedings during the pendency of two arbitrations. The first arbitration resulted in a judicially-confirmed award in favor of Standard Security Life and Madison National Life in the amount of $5,641,000, which the Plaintiff has satisfied. The Company received payment on September 9, 2020 and recorded it in other income on the Consolidated Statement of Income in the third quarter of 2020. The second arbitration resulted in no monetary obligations owed by any of the parties. The Plaintiff has filed a motion for leave to file a Second Amended Complaint. The Defendants have until August 9, 2021 to file an opposition to the motion for leave to amend. Multistate Market Conduct Examination (“MCE”) As previously disclosed, our subsidiaries Standard Security Life, Madison National Life and Independence American Insurance Company were selected for MCE related to our short-term medical (“STM”), limited medical and fixed indemnity limited health insurance products for the period of January 1, 2014 through September 30, 2017. The insurance departments of five jurisdictions (Delaware, Wisconsin, District of Columbia, Kansas and South Dakota) served as lead states, and the District of Columbia Department of Insurance, Securities and Banking and the Delaware Department of Insurance served as the managing lead states of the MCE. In addition to the five lead states, 37 other states participated in the MCE. Each of Standard Security Life, Madison National Life and Independence American Insurance Company responded to inquiries and document production requests in the MCE and proactively communicated and cooperated with the applicable regulatory agencies for the MCE. Each of these subsidiaries also provided a detailed action plan to regulators that summarized its enhanced compliance and control mechanisms. In an effort to avoid long‐term litigation and/or administrative proceedings that would be required to resolve disputes between Standard Security Life, Madison National Life and Independence American Insurance Company and the states involved in the MCE, the Lead States and Standard Security Life, Madison National Life and Independence American Insurance Company entered into separate RSAs on July 14, 2020. The RSAs require the implementation of a compliance plan, impose certain requirements related to specified business practices and monetary payments. The thirty-seven participating states adopted the RSAs. The Company accrued $3,660,000 in accounts payable, accruals and other liabilities on the Consolidated Balance Sheet in the second quarter of 2020 and processed payment in October 2020. As set forth in the RSAs, Standard Security Life, Madison National Life and Independence American Insurance Company deny any wrongdoing or violation of any applicable laws or regulations, and the entry into the RSAs is not an admission or acknowledgment of any wrongdoing or liability. In accordance with the RSAs, the Monitoring Period commenced and Standard Security Life, Madison National Life and Independence American Insurance Company continue to comply. |
Segment Reporting Disclosure _T
Segment Reporting Disclosure [Text Block] | 6 Months Ended |
Jun. 30, 2021 | |
Notes | |
Segment Reporting Disclosure | Note 16. Segment Reporting The Insurance Group principally engages in the life and health insurance business. Taxes and general expenses associated with parent company activities are included in Corporate. Identifiable assets by segment are those assets that are utilized in each segment and are allocated based upon the mean reserves and liabilities of each such segment. Corporate assets are composed principally of cash equivalents, resale agreements, fixed maturities, equity securities, partnership interests and certain other investments. Information by business segment is presented below for the periods indicated (in thousands): Three Months Ended Six Months Ended June 30, June 30, 20 21 2020 2021 2020 Revenues: Specialty Health $ 23,862 $ 30,718 $ 50,133 $ 62,924 Group disability and life 25,143 24,076 50,264 48,161 Individual life, annuities and other (A) 183 490 392 808 Corporate 268 897 791 1,512 49,456 56,181 101,580 113,405 Net investment gains (losses) (126) 274 91 117 Total revenues $ 49,330 $ 56,455 $ 101,671 $ 113,522 Income before income taxes Specialty Health (C) $ (841) $ (5,329) $ (2,732) $ (5,935) Group disability and life 3,770 4,353 6,900 6,190 Individual life, annuities and other (A) (B) (263) (140) (247) (283) Corporate (3,244) (2,016) (5,056) (3,229) (578) (3,132) (1,135) (3,257) Net investment gains (losses) (126) 274 91 117 Loss from continuing operations before income taxes $ (704) $ (2,858) $ (1,044) $ (3,140) (A) (B) (C) |
Subsequent Events _Text Block_
Subsequent Events [Text Block] | 6 Months Ended |
Jun. 30, 2021 | |
Notes | |
Subsequent Events | Note 17. Subsequent Events On July 14, 2021, IHC and its wholly owned subsidiary ICC entered into a Stock Purchase Agreement with Horace Mann Educators Corporation to sell all of the issued and outstanding capital stock of Madison National Life, a Wisconsin insurance company wholly owned by ICC, for an aggregate purchase price of $172,500,000 in cash. In addition, if Madison National Life reaches specified financial targets in 2023, IHC will receive an additional purchase price of up to $12,500,000. The transaction has been approved by the Board of Directors of IHC, and IHC’s majority stockholders have entered into a voting agreement under which such majority stockholders agreed to approve the transaction. The closing is expected no earlier than January 1, 2022. The transaction is subject to customary closing conditions, including applicable regulatory approvals, one of which is the approval by the Wisconsin Office of the Commissioner of Insurance. The aforementioned disposal plan represents a strategic shift that will have a major effect on the Company’s operations and financial results and as such, will qualify for reporting as discontinued operations in the third quarter 2021. |
Organization, Consolidation, _2
Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]: Basis of Accounting, Policy [Policy Text Block] (Policies) | 6 Months Ended |
Jun. 30, 2021 | |
Policies | |
Basis of Accounting, Policy | The unaudited Condensed Consolidated Financial Statements have been prepared in conformity with U.S. generally accepted accounting principles ("GAAP") for interim financial statements and with the instructions to Form 10-Q and Article 10 of Regulation S-X and, therefore, do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. The unaudited Condensed Consolidated Financial Statements include the accounts of IHC and its consolidated subsidiaries. All significant intercompany transactions have been eliminated in consolidation. The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect: (i) the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements; and (ii) the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. IHC’s Annual Report on Form 10-K as filed with the Securities and Exchange Commission should be read in conjunction with the accompanying unaudited Condensed Consolidated Financial Statements. During the second quarter of 2021, the Board of Directors committed to various plans for the disposal of several business operations (see Note 2). Each plan represents a strategic shift that will have a major effect on the Company’s operations and financial results and as such, they each qualify for reporting as discontinued operations in the second quarter 2021. The assets, liabilities, and related income and expenses associated with each disposal group are presented as discontinued operations in the accompanying condensed consolidated financial statements and Notes thereto for all periods presented. In March 2020, the World Health Organization declared the outbreak of COVID-19 a global health pandemic and the United States declared a national health emergency. COVID-19 has led to largescale disruption in the global economy, market instability and widespread unemployment in the United States. The COVID-19 outbreak continues to be a fluid situation and as it evolves, the duration of COVID-19 and its potential effects on our business cannot be certain. Regulatory mandates have affected, and we anticipate will continue to impact, the insurance industry. We currently cannot predict if there will be a material impact to our business, results of operations or financial condition in future reporting periods. Consequently, future changes in market conditions may impact estimates used in the preparation of our financial statements associated with evaluations of goodwill and other intangible assets for impairment, estimates associated with the determination of valuation allowances related to net operating loss carryforwards, and estimates of certain losses under insurance contracts. These estimates may all be subject to substantial adjustments in future periods. In addition, volatile market conditions may result in declines in the fair value of our investment portfolio and possible impairments of certain securities. In the opinion of management, all adjustments (consisting only of normal recurring accruals) that are necessary for a fair presentation of the consolidated financial position and results of operations for the interim periods have been included. The condensed consolidated results of operations for the three months and six months ended June 30, 2021 are not necessarily indicative of the results to be anticipated for the entire year. |
Organization, Consolidation, _3
Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]: Reclassification, Policy [Policy Text Block] (Policies) | 6 Months Ended |
Jun. 30, 2021 | |
Policies | |
Reclassification, Policy | Certain amounts in prior year’s condensed consolidated financial statements and Notes thereto have been reclassified to conform to the 2021 presentation, primarily for the effects of discontinued operations. |
Organization, Consolidation, _4
Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]: New Accounting Pronouncements, Policy [Policy Text Block] (Policies) | 6 Months Ended |
Jun. 30, 2021 | |
Policies | |
New Accounting Pronouncements, Policy | Recently Adopted Accounting Standards In December 2019, the Financial Accounting Standard Board (“FASB”) issued guidance to simplify the accounting for income taxes. The guidance eliminates certain exceptions related to the approach for intra-period tax allocation, the methodology for calculating income taxes in an interim period, and the recognition of deferred tax liabilities related to changes in ownership of equity method investments and foreign subsidiaries. The guidance also simplifies aspects of accounting for franchise taxes, the requirement to allocate current and deferred tax expense to legal entities not subject to tax in its separate financial statements, enacted changes in tax laws or rates, and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. The adoption of this guidance did not have a material effect on the Company’s consolidated financial statements. Recently Issued Accounting Standards Not Yet Adopted In August 2018, the FASB issued guidance to improve existing measurements, presentation and disclosure requirements for long-duration contracts issued by insurance entities. The amendments in this guidance requires an entity to (1) review and update assumptions used to measure cash flows at least annually as well as update the discount rate assumption at each reporting date; (2) measure market risk benefits associated with deposit contracts at fair value; (3) disclose liability rollforwards and information about significant inputs, judgements assumptions, and methods used in measurement. Additionally, it simplifies the amortization of deferred acquisition costs and other balances on a constant level basis over the expected term of the related contracts. In 2019, the FASB delayed the original effective dates. For smaller reporting companies, the amendments in this guidance are now effective for fiscal years beginning after December 15, 2023, and for interim periods within fiscal years beginning after December 15, 2024. Upon adoption, the amendments in this guidance should be applied to contracts in-force as of the beginning of the earliest period presented with a cumulative adjustment to beginning retained earnings. Management is evaluating the requirements and potential impact that the adoption of this guidance will have on the Company’s consolidated financial statements. In June 2016, the FASB issued guidance requiring financial assets measured at amortized cost basis to be presented at the net amount expected to be collected. An allowance for credit losses will be deducted from the amortized cost basis to present the net carrying value at the amount expected to be collected with changes in the allowance recorded in earnings. Credit losses relating to available-for-sale debt securities will also be recorded through an allowance for credit losses rather than the currently applied U.S. GAAP method of taking a permanent impairment of the security, which would be limited to the amount by which fair value is below the amortized cost. Certain existing requirements used to evaluate credit losses have been removed. In 2019, the FASB provided transition relief by providing entities with an option to irrevocably elect the fair value option on an instrument-by-instrument basis for eligible instruments upon adoption and delayed the original effective dates. For smaller reporting companies, the amendments in this guidance are now effective for fiscal years beginning after December 15, 2022, including interim periods within those years. Early adoption is permitted. The amendments in this guidance should be applied through a cumulative effect adjustment to retained earnings upon adoption as of the beginning of the first reporting period in which the guidance is effective. Management is evaluating the requirements and potential impact that the adoption of this guidance will have on the Company’s consolidated financial statements. |
Disposal Groups, Including Di_2
Disposal Groups, Including Discontinued Operations, Disclosure: Disposal Groups, Including Discontinued Operations (Tables) | 6 Months Ended |
Jun. 30, 2021 | |
Tables/Schedules | |
Disposal Groups, Including Discontinued Operations | The following is a reconciliation, by disposal group, of the carrying amounts of major classes of assets and liabilities included in discontinued operations on the Condensed Consolidated Balance Sheets for the periods indicated (in thousands): June 30, 2021 SSL Sale Pets Sale Total Major classes of assets: Investments and cash $ 164,346 $ 144,688 $ 309,034 Goodwill - 41,716 41,716 Other assets 30,020 35,392 65,412 Assets attributable to discontinued operations $ 194,366 $ 221,796 $ 416,162 Major classes of liabilities: Policy benefits and claims $ 56,987 $ 12,743 $ 69,730 Unearned premiums 26,778 6,080 32,858 Other liabilities 12,500 5,092 17,592 Liabilities attributable to discontinued operations $ 96,265 $ 23,915 $ 120,180 December 31, 2020 SSL Sale Pets Sale Total Major classes of assets included in discontinued operations: Investments and cash $ 114,916 $ 149,844 $ 264,760 Goodwill - 62,414 62,414 Other assets 18,787 29,730 48,517 Assets attributable to discontinued operations $ 133,703 $ 241,988 $ 375,691 Major classes of liabilities included in discontinued operations: Policy benefits and claims $ 34,500 $ 11,775 $ 46,275 Unearned premiums 5,208 5,629 10,837 Other liabilities 9,316 9,511 18,827 Liabilities attributable to discontinued operations $ 49,024 $ 26,915 $ 75,939 The following is a reconciliation, by disposal group, of the major line items constituting the pretax profit of discontinued operations to the income from discontinued operations, net of tax, as shown on the Condensed Consolidated Statements of Income for the periods indicated (in thousands): For the Three Months Ended June 30, 2021 SSL Sale Pets Sale Total Revenues $ 50,342 $ 33,080 $ 83,422 Expenses: Insurance benefits, claims and reserves 24,341 18,442 42,783 Selling, general and administrative expenses 7,394 14,592 21,986 Pretax income of discontinued operations during phase-out 18,607 46 18,653 Pretax provision for loss on disposal (402) (410) (812) Pretax gain on disposal of discontinued operations - 74,534 74,534 Total pretax income from discontinued operations 18,205 74,170 92,375 Income tax expense on discontinued operations 3,836 11,734 15,570 Income from discontinued operations, net of tax $ 14,369 $ 62,436 $ 76,805 For the Three Months Ended June 30, 2020 SSL Sale Pets Sale Total Revenues $ 30,442 $ 20,407 $ 50,849 Expenses: Insurance benefits, claims and reserves 22,152 11,098 33,250 Selling, general and administrative expenses 6,150 7,855 14,005 Pretax income of discontinued operations during phase-out 2,140 1,454 3,594 Pretax provision for loss on disposal - - - Pretax gain on disposal of discontinued operations - - - Total pretax income from discontinued operations 2,140 1,454 3,594 Income tax expense on discontinued operations 822 442 1,264 Income from discontinued operations, net of tax $ 1,318 $ 1,012 $ 2,330 For the Six Months Ended June 30, 2021 SSL Sale Pets Sale Total Revenues $ 93,738 $ 61,999 $ 155,737 Expenses: Insurance benefits, claims and reserves 53,865 34,374 88,239 Selling, general and administrative expenses 14,850 26,796 41,646 Pretax income of discontinued operations during phase-out 25,023 829 25,852 Pretax provision for loss on disposal (402) (410) (812) Pretax gain on disposal of discontinued operations - 74,534 74,534 Total pretax income from discontinued operations 24,621 74,953 99,574 Income tax expense on discontinued operations 5,151 11,875 17,026 Income from discontinued operations, net of tax $ 19,470 $ 63,078 $ 82,548 For the Six Months Ended June 30, 2020 SSL Sale Pets Sale Total Revenue $ 59,943 $ 37,838 $ 97,781 Expenses: Insurance benefits, claims and reserves 40,560 20,459 61,019 Selling, general and administrative expenses 13,004 14,515 27,519 Pretax income of discontinued operations during phase-out 6,379 2,864 9,243 Pretax provision for loss on disposal - - - Pretax gain on disposal of discontinued operations - - - Total pretax income from discontinued operations 6,379 2,864 9,243 Income tax expense on discontinued operations 1,689 741 2,430 Income from discontinued operations, net of tax $ 4,690 $ 2,123 $ 6,813 |
Earnings Per Share _Text Bloc_2
Earnings Per Share [Text Block]: Earnings Per Share, Schedule Of Net Income Attributable To Parent (Tables) | 6 Months Ended |
Jun. 30, 2021 | |
Tables/Schedules | |
Earnings Per Share, Schedule Of Net Income Attributable To Parent | Three Months Ended Six Months Ended June 30, June 30, 2021 2020 2021 2020 Income from continuing operations attributable to IHC $ (436) $ (1,835) $ (612) $ (1,987) Income from discontinued operations attributable to IHC $ 76,907 $ 2,256 $ 82,704 $ 6,686 Net income attributable to IHC $ 76,471 $ 421 $ 82,092 $ 4,699 |
Cash and Cash Equivalents Dis_2
Cash and Cash Equivalents Disclosure: Schedule of Cash and Cash Equivalents (Tables) | 6 Months Ended |
Jun. 30, 2021 | |
Tables/Schedules | |
Schedule of Cash and Cash Equivalents | June 30, 2021 2020 Cash and cash equivalents $ 22,834 $ 11,655 Restricted cash in other assets 418 985 Cash, cash equivalents and restricted cash in discontinued operations 3,773 11,563 Total cash, cash equivalents and restricted cash including discontinued operations $ 27,025 $ 24,203 |
Investments in Debt and Marke_2
Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]: Debt Securities, Available-for-sale [Table Text Block] (Tables) | 6 Months Ended |
Jun. 30, 2021 | |
Tables/Schedules | |
Debt Securities, Available-for-sale | June 30, 2021 GROSS GROSS AMORTIZED UNREALIZED UNREALIZED FAIR COST GAINS LOSSES VALUE FIXED MATURITIES AVAILABLE-FOR-SALE: Corporate securities $ 75,245 $ 1,583 $ (779) $ 76,049 CMOs – residential (1) 3,071 118 (5) 3,184 U.S. Government obligations 23,029 273 - 23,302 Agency MBS - residential (2) 35 - (4) 31 GSEs (3) 2,969 - (84) 2,885 States and political subdivisions 74,086 1,261 (384) 74,963 Foreign government obligations 3,144 151 - 3,295 Total fixed maturities $ 181,579 $ 3,386 $ (1,256) $ 183,709 December 31, 2020 GROSS GROSS AMORTIZED UNREALIZED UNREALIZED FAIR COST GAINS LOSSES VALUE FIXED MATURITIES AVAILABLE-FOR-SALE: Corporate securities $ 91,802 $ 2,174 $ (1,302) $ 92,674 CMOs – residential (1) 3,439 146 (2) 3,583 U.S. Government obligations 23,397 414 - 23,811 Agency MBS - residential (2) 39 - (5) 34 GSEs (3) 3,055 - (81) 2,974 States and political subdivisions 82,910 1,768 (452) 84,226 Foreign government obligations 3,211 206 - 3,417 Total fixed maturities $ 207,853 $ 4,708 $ (1,842) $ 210,719 (1) (2) (3) |
Investments in Debt and Marke_3
Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]: Investments Classified by Contractual Maturity Date (Tables) | 6 Months Ended |
Jun. 30, 2021 | |
Tables/Schedules | |
Investments Classified by Contractual Maturity Date | AMORTIZED FAIR COST VALUE Due in one year or less $ 36,481 $ 36,938 Due after one year through five years 87,377 89,128 Due after five years through ten years 20,124 20,292 Due after ten years 31,522 31,252 Fixed maturities with no single maturity date 6,075 6,099 $ 181,579 $ 183,709 |
Investments in Debt and Marke_4
Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]: Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value (Tables) | 6 Months Ended |
Jun. 30, 2021 | |
Tables/Schedules | |
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value | June 30, 2021 Less than 12 Months 12 Months or Longer Total Fair Unrealized Fair Unrealized Fair Unrealized Value Losses Value Losses Value Losses Corporate securities $ 19,962 $ 740 $ 4,503 $ 39 $ 24,465 $ 779 CMOs-residential 707 5 - - 707 5 Agency MBS - residential 31 4 - - 31 4 GSEs - 2,886 84 2,886 84 States and political subdivisions 10,319 76 8,813 308 19,132 384 Fixed maturities in an unrealized loss position $ 31,019 $ 825 $ 16,202 $ 431 $ 47,221 $ 1,256 Number of fixed maturities in an unrealized loss position 9 14 23 December 31, 2020 Less than 12 Months 12 Months or Longer Total Fair Unrealized Fair Unrealized Fair Unrealized Value Losses Value Losses Value Losses Corporate securities $ 23,591 $ 458 $ 8,845 $ 844 $ 32,436 $ 1,302 CMOs-residential 748 2 - - 748 2 Agency MBS - residential 34 5 - - 34 5 GSEs - - 2,974 81 2,974 81 States and political subdivisions 16,983 150 6,108 302 23,091 452 Fixed maturities in an unrealized loss position $ 41,356 $ 615 $ 17,927 $ 1,227 $ 59,283 $ 1,842 Number of fixed maturities in an unrealized loss position 20 13 33 |
Investments in Debt and Marke_5
Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]: Realized Gain (Loss) on Investments (Tables) | 6 Months Ended |
Jun. 30, 2021 | |
Tables/Schedules | |
Realized Gain (Loss) on Investments | Three Months Ended Six Months Ended June 30, June 30, 2021 2020 2021 2020 Realized gains (losses): Fixed maturities available-for-sale $ (126) $ 50 $ 46 $ 284 Equity securities - - 292 - Total realized gains (losses) on debt and equity securities (126) 50 338 284 Unrealized gains (losses) on equity securities - 214 (247) (184) Gains (losses) on debt and equity securities (126) 264 91 100 Gains (losses) on other investments - 10 - 17 Net investment gains $ (126) $ 274 $ 91 $ 117 |
Fair Value Disclosures _Text _2
Fair Value Disclosures [Text Block]: Fair Value, Assets Measured on Recurring Basis (Tables) | 6 Months Ended |
Jun. 30, 2021 | |
Tables/Schedules | |
Fair Value, Assets Measured on Recurring Basis | June 30, 2021 Level 1 Level 2 Level 3 Total FINANCIAL ASSETS: Fixed maturities available-for-sale: Corporate securities $ - $ 76,049 $ - $ 76,049 CMOs - residential - 3,184 - 3,184 US Government obligations - 23,302 - 23,302 Agency MBS - residential - 31 - 31 GSEs - 2,885 - 2,885 States and political subdivisions - 73,949 1,014 74,963 Foreign government obligations - 3,295 - 3,295 Total fixed maturities - 182,695 1,014 183,709 Total Financial Assets $ - $ 182,695 $ 1,014 $ 183,709 December 31, 2020 Level 1 Level 2 Level 3 Total FINANCIAL ASSETS: Fixed maturities available-for-sale: Corporate securities $ - $ 92,674 $ - $ 92,674 CMOs - residential - 3,583 - 3,583 US Government obligations - 23,811 - 23,811 Agency MBS - residential - 34 - 34 GSEs - 2,974 - 2,974 States and political subdivisions - 83,130 1,096 84,226 Foreign government obligations - 3,417 - 3,417 Total fixed maturities - 209,623 1,096 210,719 Equity securities: Common stocks 1,753 - - 1,753 Total equity securities 1,753 - - 1,753 Total Financial Assets $ 1,753 $ 209,623 $ 1,096 $ 212,472 |
Fair Value Disclosures _Text _3
Fair Value Disclosures [Text Block]: Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation (Tables) | 6 Months Ended |
Jun. 30, 2021 | |
Tables/Schedules | |
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation | Three Months Ended June 30, 2021 2020 States and Total States and Total Political Level 3 Political Level 3 Subdivisions Assets Subdivisions Assets Beginning b alance $ 1,055 $ 1,055 $ 1,214 $ 1,214 Increases (decreases) recognized in earnings: Net investment gains - - - - Gains (losses) included in other comprehensive income (loss): Net unrealized gains (losses) (4) (4) (5) (5) Repayments and amortization of fixed maturities (37) (37) (34) (34) Balance at end of period $ 1,014 $ 1,014 $ 1,175 $ 1,175 Six Months Ended June 30, 2021 2020 States and Total States and Total Political Level 3 Political Level 3 Subdivisions Assets Subdivisions Assets Beginning b alance $ 1,096 $ 1,096 $ 1,251 $ 1,251 Increases (decreases) recognized in earnings: Net investment gains - - - - Gains (losses) included in other comprehensive income (loss): Net unrealized gains (losses) (8) (8) (9) (9) Repayments and amortization of fixed maturities (74) (74) (67) (67) Balance at end of period $ 1,014 $ 1,014 $ 1,175 $ 1,175 |
Fair Value Disclosures _Text _4
Fair Value Disclosures [Text Block]: Fair Value, by Balance Sheet Grouping (Tables) | 6 Months Ended |
Jun. 30, 2021 | |
Tables/Schedules | |
Fair Value, by Balance Sheet Grouping | June 30, 2021 December 31, 2020 Level 1 Level 2 Level 1 Level 2 Fair Fair Carrying Fair Fair Carrying Value Value Value Value Value Value FINANCIAL ASSETS: Short-term investments $ 1,550 $ - $ 1,550 $ 1,568 $ - $ 1,568 Securities purchased under agreements to resell 70,323 - 70,323 33,038 - 33,038 FINANCIAL LIABILITIES: Funds on deposit $ - $ 142,155 $ 142,155 $ - $ 141,376 $ 141,376 Other policyholders’ funds - 11,988 11,988 - 12,001 12,001 |
Business Combination Disclosu_2
Business Combination Disclosure: Schedule of Recognized Identified Assets Acquired and Liabilities Assumed (Tables) | 6 Months Ended |
Jun. 30, 2021 | |
Abacus | |
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed | Other assets $ 350 Total identifiable assets 350 Other liabilities 575 Total liabilities 575 Net identifiable assets (liabilities) acquired $ (225) |
Torchlight Technology Group Acquisition Member | |
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed | Cash $ 333 Intangible assets 2,700 Other assets 2,132 Total identifiable assets 5,165 Other liabilities 1,227 Total liabilities 1,227 Net identifiable assets acquired $ 3,938 |
Goodwill and Intangible Asset_2
Goodwill and Intangible Assets Disclosure [Text Block]: Schedule of Finite-Lived Intangible Assets (Tables) | 6 Months Ended |
Jun. 30, 2021 | |
Tables/Schedules | |
Schedule of Finite-Lived Intangible Assets | June 30, 2021 December 31, 2020 Gross Gross Carrying Accumulated Carrying Accumulated Amount Amortization Amount Amortization Finite-lived Intangible Assets: Agent and broker relationships $ 6,583 $ 4,599 $ 7,583 $ 5,385 Software systems 1,500 294 1,500 167 Total finite-lived $ 8,083 $ 4,893 $ 9,083 $ 5,552 |
Goodwill and Intangible Asset_3
Goodwill and Intangible Assets Disclosure [Text Block]: Schedule of Indefinite-Lived Intangible Assets (Tables) | 6 Months Ended |
Jun. 30, 2021 | |
Tables/Schedules | |
Schedule of Indefinite-Lived Intangible Assets | June 30, December 31, 2021 2020 Indefinite-lived Intangible Assets: Insurance licenses $ 477 $ 477 Total indefinite-lived $ 477 $ 477 |
Revenue from Contract with Cu_2
Revenue from Contract with Customer: Disaggregation of Revenue (Tables) | 6 Months Ended |
Jun. 30, 2021 | |
Tables/Schedules | |
Disaggregation of Revenue | Three Months Ended Six Months Ended June 30, June 30, 2021 2020 2021 2020 Commissions $ 1,416 1,932 4,297 $ 3,672 Administrative Fees 80 581 177 1,069 Marketing Fees 254 292 559 643 Enrollment Platform Fees 529 455 1,029 973 Lead and Referral Fees 2,633 588 4,945 854 Payment Plan, Application and Other Fees 32 59 72 130 Total Fee Income $ 4,944 3,907 11,079 $ 7,341 |
Revenue from Contract with Cu_3
Revenue from Contract with Customer: Contract with Customer, Contract Asset, Contract Liability, and Receivable (Tables) | 6 Months Ended |
Jun. 30, 2021 | |
Tables/Schedules | |
Contract with Customer, Contract Asset, Contract Liability, and Receivable | Six Months Ended June 30, 2021 Beginning Balance $ 7,760 Commissions recognized during the period 4,708 Commission adjustments related to prior periods (418) Cash receipts (3,251) Ending Balance $ 8,799 |
Liability for Future Policy B_2
Liability for Future Policy Benefits and Unpaid Claims Disclosure [Text Block]: Schedule of Liability for Unpaid Claims and Claims Adjustment Expense (Tables) | 6 Months Ended |
Jun. 30, 2021 | |
Schedule of Liability for Unpaid Claims and Claims Adjustment Expense | For the Six Months Ended June 30, 2021 Specialty Group All Other Health Disability Lines Total Balance at beginning of year $ 31,680 $ 80,976 $ 20,301 $ 132,957 Less: reinsurance recoverable 1,776 22,472 11,878 36,126 Net balance at beginning of year 29,904 58,504 8,423 96,831 Amount incurred, related to: Current year 16,631 20,031 11,947 48,609 Prior years (4,634) (4,033) (1,132) (9,799) Total incurred 11,997 15,998 10,815 38,810 Amount paid, related to: Current year 4,461 3,922 6,885 15,268 Prior years 12,080 11,488 3,667 27,235 Total paid 16,541 15,410 10,552 42,503 Net balance at end of period 25,360 59,092 8,686 93,138 Plus: reinsurance recoverable 1,161 22,492 11,024 34,677 Balance at end of period $ 26,521 $ 81,584 $ 19,710 $ 127,815 For the Six Months Ended June 30, 2020 Specialty Group All Other Health Disability Lines Total Balance at beginning of year $ 35,530 $ 80,079 $ 19,874 $ 135,483 Less: reinsurance recoverable 1,717 23,322 11,954 36,993 Net balance at beginning of year 33,813 56,757 7,920 98,490 Amount incurred, related to: Current year 24,522 19,093 11,182 54,797 Prior years (1,972) (1,553) (3,201) (6,726) Total incurred 22,550 17,540 7,981 48,071 Amount paid, related to: Current year 7,064 4,010 4,979 16,053 Prior years 17,530 12,125 2,155 31,810 Total paid 24,594 16,135 7,134 47,863 Net balance at end of period 31,769 58,162 8,767 98,698 Plus: reinsurance recoverable 1,802 22,463 11,074 35,339 Balance at end of period $ 33,571 $ 80,625 $ 19,841 $ 134,037 |
Specialty Health Segment Member | Health Insurance Product Line | |
Schedule of Liability for Unpaid Claims and Claims Adjustment Expense | Specialty Health Segment Health Insurance Claims Six Months Ended June 30, 2021 2020 Balance at beginning of year $ 28,295 $ 31,259 Less: reinsurance recoverable 1,766 1,113 Net balance at beginning of year 26,529 30,146 Amount incurred, related to: Current year 15,818 23,627 Prior years (3,658) (1,184) Total incurred 12,160 22,443 Amount paid, related to: Current year 4,319 8,260 Prior years 11,992 16,382 Total paid 16,311 24,642 Net balance at end of period 22,378 27,947 Plus: reinsurance recoverable 1,158 1,406 Balance at end of period $ 23,536 $ 29,353 |
Liability for Future Policy B_3
Liability for Future Policy Benefits and Unpaid Claims Disclosure [Text Block]: Schedule Of Prior Year Claims And Claims Adjustment Expense Disclosure (Tables) | 6 Months Ended |
Jun. 30, 2021 | |
Specialty Health Segment, All Product Lines | |
Schedule Of Prior Year Claims And Claims Adjustment Expense Disclosure | Six Months Ended June 30, Specialty Health segment: 2021 2020 Short-term Medical (“STM”) $ 1,676 $ 286 Occupational Accident 963 798 Fixed Indemnity Limited Benefit 862 (736) Limited Medical 197 241 Critical Illness 196 397 Group Gap 356 513 All other specialty health lines 384 473 Total Specialty Health segment $ 4,634 $ 1,972 |
Stockholders' Equity Note Dis_2
Stockholders' Equity Note Disclosure [Text Block]: Schedule of Accumulated Other Comprehensive Income (Loss) (Tables) | 6 Months Ended |
Jun. 30, 2021 | |
Tables/Schedules | |
Schedule of Accumulated Other Comprehensive Income (Loss) | Three Months Ended Six Months Ended June 30, June 30, 2021 2020 2021 2020 Beginning balance $ 2,268 $ 1,101 $ 4,197 $ 1,212 Other comprehensive income (loss): Other comprehensive income (loss) before reclassifications 784 1,810 (1,013) 2,544 Amounts reclassified from accumulated OCI 168 (57) 36 (902) Net other comprehensive income (loss) 952 1,753 (977) 1,642 Ending balance $ 3,220 $ 2,854 $ 3,220 $ 2,854 |
Stockholders' Equity Note Dis_3
Stockholders' Equity Note Disclosure [Text Block]: Reclassification out of Accumulated Other Comprehensive Income (Tables) | 6 Months Ended |
Jun. 30, 2021 | |
Tables/Schedules | |
Reclassification out of Accumulated Other Comprehensive Income | Three Months Ended Six Months Ended June 30, June 30, 2021 2020 2021 2020 Unrealized gains (losses) on available-for-sale securities reclassified during the period to the following income statement line items: Net investment gains (losses) $ (125) $ 47 $ 47 $ 284 Income (loss) from continuing operations before income taxes (125) 47 47 284 Income tax expense (benefit) (28) 10 9 60 Income (loss) from continuing operations, net of tax (97) 37 38 224 Total pretax income (loss) from discontinued operations (90) 25 (94) 858 Income tax expense (benefit) on discontinued operations (19) 5 (20) 180 Income from discontinued operations, net of tax (71) 20 (74) 678 Net income (loss) $ (168) $ 57 $ (36) $ 902 |
Segment Reporting Disclosure _2
Segment Reporting Disclosure [Text Block]: Schedule of Segment Reporting Information, by Segment (Tables) | 6 Months Ended |
Jun. 30, 2021 | |
Tables/Schedules | |
Schedule of Segment Reporting Information, by Segment | Three Months Ended Six Months Ended June 30, June 30, 20 21 2020 2021 2020 Revenues: Specialty Health $ 23,862 $ 30,718 $ 50,133 $ 62,924 Group disability and life 25,143 24,076 50,264 48,161 Individual life, annuities and other (A) 183 490 392 808 Corporate 268 897 791 1,512 49,456 56,181 101,580 113,405 Net investment gains (losses) (126) 274 91 117 Total revenues $ 49,330 $ 56,455 $ 101,671 $ 113,522 Income before income taxes Specialty Health (C) $ (841) $ (5,329) $ (2,732) $ (5,935) Group disability and life 3,770 4,353 6,900 6,190 Individual life, annuities and other (A) (B) (263) (140) (247) (283) Corporate (3,244) (2,016) (5,056) (3,229) (578) (3,132) (1,135) (3,257) Net investment gains (losses) (126) 274 91 117 Loss from continuing operations before income taxes $ (704) $ (2,858) $ (1,044) $ (3,140) (A) (B) (C) |
Organization, Consolidation, _5
Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block] (Details) | Jun. 30, 2021 |
GeneveAffiliatedEntityMember | |
EntityCommonStockOutstandingOwnershipPercent | 62.00% |
Disposal Groups, Including Di_3
Disposal Groups, Including Discontinued Operations, Disclosure (Details) - USD ($) $ in Thousands | Jun. 30, 2021 | Jun. 30, 2021 | Jun. 30, 2020 | Jun. 30, 2021 | Jun. 30, 2020 | Jul. 29, 2021 | May 17, 2021 | Apr. 14, 2021 | Dec. 31, 2020 |
Equity Method Investments | $ 33,762 | $ 33,762 | $ 33,762 | $ 0 | |||||
Discontinued Operation, Tax Effect of Discontinued Operation | 15,570 | $ 1,264 | 17,026 | $ 2,430 | |||||
AMICSubsidiariesMember | |||||||||
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | 8,281 | ||||||||
Operating Loss Carryforwards | $ 46,116 | ||||||||
Discontinued Operations | |||||||||
Discontinued Operation, Income (Loss) from Discontinued Operation During Phase-out Period, before Income Tax | 18,653 | 3,594 | 25,852 | 9,243 | |||||
Cash Provided by (Used in) Operating Activities, Discontinued Operations | 45,917 | 26,813 | |||||||
Cash Provided by (Used in) Investing Activities, Discontinued Operations | (88,501) | (29,753) | |||||||
Discontinued Operation, Tax Effect of Discontinued Operation | 15,570 | 1,264 | 17,026 | 2,430 | |||||
Discontinued Operation, Tax Effect of Gain (Loss) from Disposal of Discontinued Operation | 11,841 | ||||||||
SSL Sale Member | Discontinued Operations | |||||||||
Disposal Group Including Discontinued Operation, Transaction Price | $ 180,000 | ||||||||
Sale Transaction, Statutory Capital And Surplus Target | $ 53,000 | ||||||||
Statutory Accounting Practices, Statutory Capital and Surplus, Balance | $ 82,091 | 82,091 | 82,091 | ||||||
Discontinued Operation, Income (Loss) from Discontinued Operation During Phase-out Period, before Income Tax | 18,607 | 2,140 | 25,023 | 6,379 | |||||
Discontinued Operation, Tax Effect of Discontinued Operation | 3,836 | 822 | 5,151 | 1,689 | |||||
SSL Sale Member | Discontinued Operations | Subsequent Event | |||||||||
Sale Transaction, Statutory Capital And Surplus Target | $ 57,000 | ||||||||
Pets Sale Member | Discontinued Operations | |||||||||
Discontinued Operation, Equity Method Investment Retained after Disposal, Ownership Interest Prior to Disposal | 70.00% | ||||||||
Discontinued Operation, Equity Method Investment Retained after Disposal, Ownership Interest after Disposal | 30.00% | ||||||||
Discontinued Operation, Income (Loss) from Discontinued Operation During Phase-out Period, before Income Tax | 46 | 1,454 | 829 | 2,864 | |||||
Discontinued Operation, Tax Effect of Discontinued Operation | 11,734 | $ 442 | 11,875 | $ 741 | |||||
Pets Sale, PetPartners Transaction | AMICSubsidiariesMember | |||||||||
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | 8,281 | ||||||||
Pets Sale, PetPartners Transaction | Discontinued Operations | |||||||||
Disposal Group Including Discontinued Operation, Transaction Price | $ 77,000 | ||||||||
Disposal Group, Including Discontinued Operation, Consideration | $ 78,779 | 78,779 | 78,779 | ||||||
Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax | 62,693 | ||||||||
Disposal Of Discontinued Operation, Transaction Costs | 6,070 | ||||||||
Loss Contingency Accrual | 6,800 | 6,800 | 6,800 | ||||||
Pets Sale, PetPartners Transaction | Discontinued Operations | Iguana Capital, Inc Member | |||||||||
Equity Method Investments | $ 33,762 | $ 33,762 | $ 33,762 | ||||||
Pets Sale, IAHC Transaction | Discontinued Operations | |||||||||
Disposal Group Including Discontinued Operation, Transaction Price | $ 190,400 |
Disposal Groups, Including Di_4
Disposal Groups, Including Discontinued Operations, Disclosure: Disposal Groups, Including Discontinued Operations (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||||
Jun. 30, 2021 | Jun. 30, 2020 | Jun. 30, 2021 | Jun. 30, 2020 | Dec. 31, 2020 | Dec. 31, 2019 | |
Disposal Group, Including Discontinued Operation, Assets | ||||||
Disposal Group, Including Discontinued Operation, Assets | $ 416,162 | $ 416,162 | $ 375,691 | |||
Disposal Group, Including Discontinued Operation, Liabilities | ||||||
Disposal Group, Including Discontinued Operation, Liabilities | 120,180 | 120,180 | $ 75,939 | |||
Discontinued Operation, Provision for Loss (Gain) on Disposal, before Income Tax | 812 | $ 0 | ||||
Discontinued Operation, Gain (Loss) from Disposal of Discontinued Operation, before Income Tax | (74,534) | 0 | ||||
Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax | 92,375 | $ 3,594 | 99,574 | 9,243 | ||
Discontinued Operation, Tax Effect of Discontinued Operation | 15,570 | 1,264 | 17,026 | 2,430 | ||
Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | 76,805 | 2,330 | 82,548 | 6,813 | ||
Discontinued Operations | ||||||
Disposal Group, Including Discontinued Operation, Assets | ||||||
Disposal Group, Including Discontinued Operation, Cash And Invesments | 309,034 | 309,034 | $ 264,760 | |||
Disposal Group, Including Discontinued Operation, Goodwill, Noncurrent | 41,716 | 41,716 | 62,414 | |||
Disposal Group, Including Discontinued Operation, Other Assets | 65,412 | 65,412 | 48,517 | |||
Disposal Group, Including Discontinued Operation, Assets | 416,162 | 416,162 | 375,691 | |||
Disposal Group, Including Discontinued Operation, Liabilities | ||||||
Disposal Group, Including Discontinued Operation, Policy Benefits And Claims | 69,730 | 69,730 | 46,275 | |||
Disposal Group, Including Discontinued Operation,Unearned Premiums | 32,858 | 32,858 | 10,837 | |||
Disposal Group, Including Discontinued Operation, Other Liabilities | 17,592 | 17,592 | 18,827 | |||
Disposal Group, Including Discontinued Operation, Liabilities | 120,180 | 120,180 | 75,939 | |||
Disposal Group, Including Discontinued Operation, Revenue | 83,422 | 50,849 | 155,737 | 97,781 | ||
Disposal Group, Including Discontinued Operation,Insurance Benefits, Claims And Reserves | 42,783 | 33,250 | 88,239 | 61,019 | ||
Disposal Group, Including Discontinued Operation, General and Administrative Expense | 21,986 | 14,005 | 41,646 | 27,519 | ||
Discontinued Operation, Income (Loss) from Discontinued Operation During Phase-out Period, before Income Tax | 18,653 | 3,594 | 25,852 | 9,243 | ||
Discontinued Operation, Provision for Loss (Gain) on Disposal, before Income Tax | 812 | 0 | 812 | 0 | ||
Discontinued Operation, Gain (Loss) from Disposal of Discontinued Operation, before Income Tax | 74,534 | 0 | 74,534 | 0 | ||
Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax | 92,375 | 3,594 | 99,574 | 9,243 | ||
Discontinued Operation, Tax Effect of Discontinued Operation | 15,570 | 1,264 | 17,026 | 2,430 | ||
Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | 76,805 | 2,330 | 82,548 | 6,813 | ||
SSL Sale Member | Discontinued Operations | ||||||
Disposal Group, Including Discontinued Operation, Assets | ||||||
Disposal Group, Including Discontinued Operation, Cash And Invesments | 164,346 | 164,346 | 114,916 | |||
Disposal Group, Including Discontinued Operation, Goodwill, Noncurrent | 0 | 0 | 0 | |||
Disposal Group, Including Discontinued Operation, Other Assets | 30,020 | 30,020 | 18,787 | |||
Disposal Group, Including Discontinued Operation, Assets | 194,366 | 194,366 | 133,703 | |||
Disposal Group, Including Discontinued Operation, Liabilities | ||||||
Disposal Group, Including Discontinued Operation, Policy Benefits And Claims | 56,987 | 56,987 | 34,500 | |||
Disposal Group, Including Discontinued Operation,Unearned Premiums | 26,778 | 26,778 | 5,208 | |||
Disposal Group, Including Discontinued Operation, Other Liabilities | 12,500 | 12,500 | 9,316 | |||
Disposal Group, Including Discontinued Operation, Liabilities | 96,265 | 96,265 | 49,024 | |||
Disposal Group, Including Discontinued Operation, Revenue | 50,342 | 30,442 | 93,738 | 59,943 | ||
Disposal Group, Including Discontinued Operation,Insurance Benefits, Claims And Reserves | 24,341 | 22,152 | 53,865 | 40,560 | ||
Disposal Group, Including Discontinued Operation, General and Administrative Expense | 7,394 | 6,150 | 14,850 | 13,004 | ||
Discontinued Operation, Income (Loss) from Discontinued Operation During Phase-out Period, before Income Tax | 18,607 | 2,140 | 25,023 | 6,379 | ||
Discontinued Operation, Provision for Loss (Gain) on Disposal, before Income Tax | 402 | 0 | 402 | 0 | ||
Discontinued Operation, Gain (Loss) from Disposal of Discontinued Operation, before Income Tax | 0 | 0 | 0 | 0 | ||
Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax | 18,205 | 2,140 | 24,621 | 6,379 | ||
Discontinued Operation, Tax Effect of Discontinued Operation | 3,836 | 822 | 5,151 | 1,689 | ||
Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | 14,369 | 1,318 | 19,470 | 4,690 | ||
Pets Sale Member | Discontinued Operations | ||||||
Disposal Group, Including Discontinued Operation, Assets | ||||||
Disposal Group, Including Discontinued Operation, Cash And Invesments | 144,688 | 144,688 | 149,844 | |||
Disposal Group, Including Discontinued Operation, Goodwill, Noncurrent | 41,716 | 41,716 | 62,414 | |||
Disposal Group, Including Discontinued Operation, Other Assets | 35,392 | 35,392 | 29,730 | |||
Disposal Group, Including Discontinued Operation, Assets | 221,796 | 221,796 | 241,988 | |||
Disposal Group, Including Discontinued Operation, Liabilities | ||||||
Disposal Group, Including Discontinued Operation, Policy Benefits And Claims | 12,743 | 12,743 | 11,775 | |||
Disposal Group, Including Discontinued Operation,Unearned Premiums | 6,080 | 6,080 | 5,629 | |||
Disposal Group, Including Discontinued Operation, Other Liabilities | 5,092 | 5,092 | 9,511 | |||
Disposal Group, Including Discontinued Operation, Liabilities | 23,915 | 23,915 | $ 26,915 | |||
Disposal Group, Including Discontinued Operation, Revenue | 33,080 | 20,407 | 61,999 | 37,838 | ||
Disposal Group, Including Discontinued Operation,Insurance Benefits, Claims And Reserves | 18,442 | 11,098 | 34,374 | 20,459 | ||
Disposal Group, Including Discontinued Operation, General and Administrative Expense | 14,592 | 7,855 | 26,796 | 14,515 | ||
Discontinued Operation, Income (Loss) from Discontinued Operation During Phase-out Period, before Income Tax | 46 | 1,454 | 829 | 2,864 | ||
Discontinued Operation, Provision for Loss (Gain) on Disposal, before Income Tax | 410 | 0 | 410 | 0 | ||
Discontinued Operation, Gain (Loss) from Disposal of Discontinued Operation, before Income Tax | 74,534 | 0 | 74,534 | 0 | ||
Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax | 74,170 | 1,454 | 74,953 | 2,864 | ||
Discontinued Operation, Tax Effect of Discontinued Operation | 11,734 | 442 | 11,875 | 741 | ||
Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | $ 62,436 | $ 1,012 | $ 63,078 | $ 2,123 |
Earnings Per Share _Text Bloc_3
Earnings Per Share [Text Block]: Earnings Per Share, Schedule Of Net Income Attributable To Parent (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2021 | Jun. 30, 2020 | Jun. 30, 2021 | Jun. 30, 2020 | |
Details | ||||
Income from continuing operations attributable to IHC | $ (436) | $ (1,835) | $ (612) | $ (1,987) |
Income from discontinued operations attributable to IHC | 76,907 | 2,256 | 82,704 | 6,686 |
Net Income (Loss) Attributable to Parent | $ 76,471 | $ 421 | $ 82,092 | $ 4,699 |
Cash and Cash Equivalents Dis_3
Cash and Cash Equivalents Disclosure: Schedule of Cash and Cash Equivalents (Details) - USD ($) $ in Thousands | Jun. 30, 2021 | Dec. 31, 2020 | Jun. 30, 2020 | Dec. 31, 2019 |
Details | ||||
Cash and Cash Equivalents, at Carrying Value | $ 22,834 | $ 31,923 | $ 11,655 | |
Restricted Cash | 418 | 985 | ||
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Disposal Group, Including Discontinued Operations | 3,773 | 11,563 | ||
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | $ 27,025 | $ 74,793 | $ 24,203 | $ 24,631 |
Investments in Debt and Marke_6
Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]: Debt Securities, Available-for-sale [Table Text Block] (Details) - USD ($) $ in Thousands | Jun. 30, 2021 | Dec. 31, 2020 |
Debt Securities, Available-for-sale, Amortized Cost | $ 181,579 | $ 207,853 |
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | 3,386 | 4,708 |
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | 1,256 | 1,842 |
Debt Securities, Available-for-sale | 183,709 | 210,719 |
Corporate Debt Securities | ||
Debt Securities, Available-for-sale, Amortized Cost | 75,245 | 91,802 |
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | 1,583 | 2,174 |
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | 779 | 1,302 |
Debt Securities, Available-for-sale | 76,049 | 92,674 |
Collateralized Mortgage Backed Securities | ||
Debt Securities, Available-for-sale, Amortized Cost | 3,071 | 3,439 |
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | 118 | 146 |
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | 5 | 2 |
Debt Securities, Available-for-sale | 3,184 | 3,583 |
US Treasury Securities | ||
Debt Securities, Available-for-sale, Amortized Cost | 23,029 | 23,397 |
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | 273 | 414 |
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | 0 | 0 |
Debt Securities, Available-for-sale | 23,302 | 23,811 |
US Government Agencies Debt Securities | ||
Debt Securities, Available-for-sale, Amortized Cost | 35 | 39 |
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | 0 | 0 |
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | 4 | 5 |
Debt Securities, Available-for-sale | 31 | 34 |
US Government-sponsored Enterprises Debt Securities | ||
Debt Securities, Available-for-sale, Amortized Cost | 2,969 | 3,055 |
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | 0 | 0 |
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | 84 | 81 |
Debt Securities, Available-for-sale | 2,885 | 2,974 |
US States and Political Subdivisions Debt Securities | ||
Debt Securities, Available-for-sale, Amortized Cost | 74,086 | 82,910 |
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | 1,261 | 1,768 |
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | 384 | 452 |
Debt Securities, Available-for-sale | 74,963 | 84,226 |
Debt Security, Government, Non-US | ||
Debt Securities, Available-for-sale, Amortized Cost | 3,144 | 3,211 |
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | 151 | 206 |
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | 0 | 0 |
Debt Securities, Available-for-sale | $ 3,295 | $ 3,417 |
Investments in Debt and Marke_7
Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]: Investments Classified by Contractual Maturity Date (Details) - USD ($) $ in Thousands | Jun. 30, 2021 | Dec. 31, 2020 |
Details | ||
Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Amortized Cost | $ 36,481 | |
Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Fair Value | 36,938 | |
Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Amortized Cost | 87,377 | |
Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Fair Value | 89,128 | |
Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after Five Through Ten Years, Amortized Cost | 20,124 | |
Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after Five Through Ten Years, Fair Value | 20,292 | |
Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 10 | 31,522 | |
Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10 | 31,252 | |
Debt Securities, Available-for-sale, Maturity, without Single Maturity Date, Amortized Cost | 6,075 | |
Debt Securities, Available-for-sale, Maturity, without Single Maturity Date, Fair Value | 6,099 | |
Debt Securities, Available-for-sale, Amortized Cost | 181,579 | $ 207,853 |
Debt Securities, Available-for-sale | $ 183,709 | $ 210,719 |
Investments in Debt and Marke_8
Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]: Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value (Details) $ in Thousands | Jun. 30, 2021USD ($) | Dec. 31, 2020USD ($) |
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months | $ 31,019 | $ 41,356 |
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss | 825 | 615 |
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer | 16,202 | 17,927 |
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss | 431 | 1,227 |
Debt Securities, Available-for-sale, Unrealized Loss Position | 47,221 | 59,283 |
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss | $ 1,256 | $ 1,842 |
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Number of Positions | 9 | 20 |
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Number of Positions | 14 | 13 |
Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions | 23 | 33 |
Corporate Debt Securities | ||
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months | $ 19,962 | $ 23,591 |
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss | 740 | 458 |
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer | 4,503 | 8,845 |
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss | 39 | 844 |
Debt Securities, Available-for-sale, Unrealized Loss Position | 24,465 | 32,436 |
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss | 779 | 1,302 |
Collateralized Mortgage Backed Securities | ||
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months | 707 | 748 |
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss | 5 | 2 |
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer | 0 | 0 |
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss | 0 | 0 |
Debt Securities, Available-for-sale, Unrealized Loss Position | 707 | 748 |
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss | 5 | 2 |
US Government Agencies Debt Securities | ||
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months | 31 | 34 |
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss | 4 | 5 |
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer | 0 | 0 |
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss | 0 | 0 |
Debt Securities, Available-for-sale, Unrealized Loss Position | 31 | 34 |
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss | 4 | 5 |
US Government-sponsored Enterprises Debt Securities | ||
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months | 0 | 0 |
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss | 0 | 0 |
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer | 2,886 | 2,974 |
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss | 84 | 81 |
Debt Securities, Available-for-sale, Unrealized Loss Position | 2,886 | 2,974 |
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss | 84 | 81 |
US States and Political Subdivisions Debt Securities | ||
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months | 10,319 | 16,983 |
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss | 76 | 150 |
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer | 8,813 | 6,108 |
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss | 308 | 302 |
Debt Securities, Available-for-sale, Unrealized Loss Position | 19,132 | 23,091 |
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss | $ 384 | $ 452 |
Investments in Debt and Marke_9
Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]: Realized Gain (Loss) on Investments (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2021 | Jun. 30, 2020 | Jun. 30, 2021 | Jun. 30, 2020 | |
Details | ||||
Debt Securities, Available-for-sale, Realized Gain (Loss), Excluding Other-than-temporary Impairment | $ (126) | $ 50 | $ 46 | $ 284 |
Equity Securities, FV-NI, Realized Gain (Loss) | 0 | 0 | 292 | 0 |
Debt and Equity Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment | (126) | 50 | 338 | 284 |
Equity Securities, FV-NI, Unrealized Gain (Loss) | 0 | 214 | (247) | (184) |
Debt and Equity Securities, Gain (Loss) | (126) | 264 | 91 | 100 |
Gain (Loss) on Sale of Other Investments | 0 | 10 | 0 | 17 |
Gain (Loss) on Investments | $ (126) | $ 274 | $ 91 | $ 117 |
Investments in Debt and Mark_10
Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block] (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2021 | Jun. 30, 2020 | Jun. 30, 2021 | Jun. 30, 2020 | |
Details | ||||
Available-for-sale Securities, Gross Realized Gains | $ 61 | $ 97 | $ 254 | $ 346 |
Available-for-sale Securities, Gross Realized Losses | $ 187 | $ 47 | 206 | 62 |
Other than Temporary Impairment Losses, Investments, Portion Recognized in Earnings, Net, Available-for-sale Securities | $ 0 | $ 0 |
Fair Value Disclosures _Text _5
Fair Value Disclosures [Text Block]: Fair Value, Assets Measured on Recurring Basis (Details) - USD ($) $ in Thousands | Jun. 30, 2021 | Dec. 31, 2020 |
Debt Securities, Available-for-sale | $ 183,709 | $ 210,719 |
Equity Securities, FV-NI, Current | 0 | 1,753 |
Corporate Debt Securities | ||
Debt Securities, Available-for-sale | 76,049 | 92,674 |
Collateralized Mortgage Backed Securities | ||
Debt Securities, Available-for-sale | 3,184 | 3,583 |
US Treasury Securities | ||
Debt Securities, Available-for-sale | 23,302 | 23,811 |
US Government Agencies Debt Securities | ||
Debt Securities, Available-for-sale | 31 | 34 |
US Government-sponsored Enterprises Debt Securities | ||
Debt Securities, Available-for-sale | 2,885 | 2,974 |
US States and Political Subdivisions Debt Securities | ||
Debt Securities, Available-for-sale | 74,963 | 84,226 |
Debt Security, Government, Non-US | ||
Debt Securities, Available-for-sale | 3,295 | 3,417 |
Fair Value, Recurring | ||
Debt Securities, Available-for-sale | 183,709 | 210,719 |
Assets, Fair Value Disclosure | 183,709 | 212,472 |
Equity Securities, FV-NI, Current | 1,753 | |
Fair Value, Recurring | Corporate Debt Securities | ||
Debt Securities, Available-for-sale | 76,049 | 92,674 |
Fair Value, Recurring | Collateralized Mortgage Backed Securities | ||
Debt Securities, Available-for-sale | 3,184 | 3,583 |
Fair Value, Recurring | US Treasury Securities | ||
Debt Securities, Available-for-sale | 23,302 | 23,811 |
Fair Value, Recurring | US Government Agencies Debt Securities | ||
Debt Securities, Available-for-sale | 31 | 34 |
Fair Value, Recurring | US Government-sponsored Enterprises Debt Securities | ||
Debt Securities, Available-for-sale | 2,885 | 2,974 |
Fair Value, Recurring | US States and Political Subdivisions Debt Securities | ||
Debt Securities, Available-for-sale | 74,963 | 84,226 |
Fair Value, Recurring | Debt Security, Government, Non-US | ||
Debt Securities, Available-for-sale | 3,295 | 3,417 |
Fair Value, Recurring | COMMON STOCK, AMOUNT | ||
Equity Securities, FV-NI, Current | 1,753 | |
Fair Value, Inputs, Level 1 | Fair Value, Recurring | ||
Debt Securities, Available-for-sale | 0 | 0 |
Assets, Fair Value Disclosure | 0 | 1,753 |
Equity Securities, FV-NI, Current | 1,753 | |
Fair Value, Inputs, Level 1 | Fair Value, Recurring | Corporate Debt Securities | ||
Debt Securities, Available-for-sale | 0 | 0 |
Fair Value, Inputs, Level 1 | Fair Value, Recurring | Collateralized Mortgage Backed Securities | ||
Debt Securities, Available-for-sale | 0 | 0 |
Fair Value, Inputs, Level 1 | Fair Value, Recurring | US Treasury Securities | ||
Debt Securities, Available-for-sale | 0 | 0 |
Fair Value, Inputs, Level 1 | Fair Value, Recurring | US Government Agencies Debt Securities | ||
Debt Securities, Available-for-sale | 0 | 0 |
Fair Value, Inputs, Level 1 | Fair Value, Recurring | US Government-sponsored Enterprises Debt Securities | ||
Debt Securities, Available-for-sale | 0 | 0 |
Fair Value, Inputs, Level 1 | Fair Value, Recurring | US States and Political Subdivisions Debt Securities | ||
Debt Securities, Available-for-sale | 0 | 0 |
Fair Value, Inputs, Level 1 | Fair Value, Recurring | Debt Security, Government, Non-US | ||
Debt Securities, Available-for-sale | 0 | 0 |
Fair Value, Inputs, Level 1 | Fair Value, Recurring | COMMON STOCK, AMOUNT | ||
Equity Securities, FV-NI, Current | 1,753 | |
Fair Value, Inputs, Level 2 | Fair Value, Recurring | ||
Debt Securities, Available-for-sale | 182,695 | 209,623 |
Assets, Fair Value Disclosure | 182,695 | 209,623 |
Equity Securities, FV-NI, Current | 0 | |
Fair Value, Inputs, Level 2 | Fair Value, Recurring | Corporate Debt Securities | ||
Debt Securities, Available-for-sale | 76,049 | 92,674 |
Fair Value, Inputs, Level 2 | Fair Value, Recurring | Collateralized Mortgage Backed Securities | ||
Debt Securities, Available-for-sale | 3,184 | 3,583 |
Fair Value, Inputs, Level 2 | Fair Value, Recurring | US Treasury Securities | ||
Debt Securities, Available-for-sale | 23,302 | 23,811 |
Fair Value, Inputs, Level 2 | Fair Value, Recurring | US Government Agencies Debt Securities | ||
Debt Securities, Available-for-sale | 31 | 34 |
Fair Value, Inputs, Level 2 | Fair Value, Recurring | US Government-sponsored Enterprises Debt Securities | ||
Debt Securities, Available-for-sale | 2,885 | 2,974 |
Fair Value, Inputs, Level 2 | Fair Value, Recurring | US States and Political Subdivisions Debt Securities | ||
Debt Securities, Available-for-sale | 73,949 | 83,130 |
Fair Value, Inputs, Level 2 | Fair Value, Recurring | Debt Security, Government, Non-US | ||
Debt Securities, Available-for-sale | 3,295 | 3,417 |
Fair Value, Inputs, Level 2 | Fair Value, Recurring | COMMON STOCK, AMOUNT | ||
Equity Securities, FV-NI, Current | 0 | |
Fair Value, Inputs, Level 3 | Fair Value, Recurring | ||
Debt Securities, Available-for-sale | 1,014 | 1,096 |
Assets, Fair Value Disclosure | 1,014 | 1,096 |
Equity Securities, FV-NI, Current | 0 | |
Fair Value, Inputs, Level 3 | Fair Value, Recurring | Corporate Debt Securities | ||
Debt Securities, Available-for-sale | 0 | 0 |
Fair Value, Inputs, Level 3 | Fair Value, Recurring | Collateralized Mortgage Backed Securities | ||
Debt Securities, Available-for-sale | 0 | 0 |
Fair Value, Inputs, Level 3 | Fair Value, Recurring | US Treasury Securities | ||
Debt Securities, Available-for-sale | 0 | 0 |
Fair Value, Inputs, Level 3 | Fair Value, Recurring | US Government Agencies Debt Securities | ||
Debt Securities, Available-for-sale | 0 | 0 |
Fair Value, Inputs, Level 3 | Fair Value, Recurring | US Government-sponsored Enterprises Debt Securities | ||
Debt Securities, Available-for-sale | 0 | 0 |
Fair Value, Inputs, Level 3 | Fair Value, Recurring | US States and Political Subdivisions Debt Securities | ||
Debt Securities, Available-for-sale | 1,014 | 1,096 |
Fair Value, Inputs, Level 3 | Fair Value, Recurring | Debt Security, Government, Non-US | ||
Debt Securities, Available-for-sale | $ 0 | 0 |
Fair Value, Inputs, Level 3 | Fair Value, Recurring | COMMON STOCK, AMOUNT | ||
Equity Securities, FV-NI, Current | $ 0 |
Fair Value Disclosures _Text _6
Fair Value Disclosures [Text Block]: Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2021 | Jun. 30, 2020 | Jun. 30, 2021 | Jun. 30, 2020 | |
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value, Beginning Balance | $ 1,055 | $ 1,214 | $ 1,096 | $ 1,251 |
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss) | (4) | (5) | (8) | (9) |
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Settlements | (37) | (34) | (74) | (67) |
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value, Ending Balance | 1,014 | 1,175 | 1,014 | 1,175 |
Gain (Loss) on Investments | ||||
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings | 0 | 0 | 0 | 0 |
US States and Political Subdivisions Debt Securities | ||||
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value, Beginning Balance | 1,055 | 1,214 | 1,096 | 1,251 |
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss) | (4) | (5) | (8) | (9) |
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Settlements | (37) | (34) | (74) | (67) |
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value, Ending Balance | 1,014 | 1,175 | 1,014 | 1,175 |
US States and Political Subdivisions Debt Securities | Gain (Loss) on Investments | ||||
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings | $ 0 | $ 0 | $ 0 | $ 0 |
Fair Value Disclosures _Text _7
Fair Value Disclosures [Text Block] (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended |
Jun. 30, 2021 | Jun. 30, 2021 | |
Details | ||
Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss), OCI | $ (4) | $ (8) |
Fair Value Disclosures _Text _8
Fair Value Disclosures [Text Block]: Fair Value, by Balance Sheet Grouping (Details) - USD ($) $ in Thousands | Jun. 30, 2021 | Dec. 31, 2020 |
Short-term Investments | $ 1,550 | $ 1,568 |
Securities Purchased under Agreements to Resell | 70,323 | 33,038 |
Deposit Contracts, Liabilities | 142,155 | 141,376 |
Policyholder Account Balance | 11,988 | 12,001 |
Estimate of Fair Value Measurement | Fair Value, Inputs, Level 1 | ||
Short-term Investments | 1,550 | 1,568 |
Securities Purchased under Agreements to Resell | 70,323 | 33,038 |
Deposit Contracts, Liabilities | 0 | 0 |
Policyholder Account Balance | 0 | 0 |
Estimate of Fair Value Measurement | Fair Value, Inputs, Level 2 | ||
Short-term Investments | 0 | 0 |
Securities Purchased under Agreements to Resell | 0 | 0 |
Deposit Contracts, Liabilities | 142,155 | 141,376 |
Policyholder Account Balance | 11,988 | 12,001 |
Reported Value Measurement | ||
Short-term Investments | 1,550 | 1,568 |
Securities Purchased under Agreements to Resell | 70,323 | 33,038 |
Deposit Contracts, Liabilities | 142,155 | 141,376 |
Policyholder Account Balance | $ 11,988 | $ 12,001 |
Investments in and Advances t_2
Investments in and Advances to Affiliates, Schedule of Investments [Text Block] (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | |||
Jun. 30, 2021 | Jun. 30, 2020 | Jun. 30, 2021 | Jun. 30, 2020 | Dec. 31, 2020 | |
Income (Loss) from Equity Method Investments | $ 4 | $ (356) | $ 64 | $ (28) | |
Ebix Health Exchange Member | Selling, General and Administrative Expenses | |||||
Related Party Transaction, Selling, General and Administrative Expenses from Transactions with Related Party | 361 | $ 423 | 762 | 899 | |
Lead Generation Company Member | Selling, General and Administrative Expenses | |||||
Related Party Transaction, Selling, General and Administrative Expenses from Transactions with Related Party | $ 1,507 | ||||
Other Investments | |||||
Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount | 2,022 | 2,022 | |||
Accounts Payable and Accrued Liabilities | Ebix Health Exchange Member | |||||
Due to Related Parties | $ 94 | $ 94 | $ 163 |
Business Combination Disclosu_3
Business Combination Disclosure (Details) - USD ($) $ in Thousands | Apr. 30, 2020 | Jan. 31, 2020 | Apr. 30, 2020 | Jan. 31, 2020 | Jun. 30, 2021 | Jun. 30, 2020 | Jun. 30, 2021 | Jun. 30, 2020 |
Revenues | $ 49,330 | $ 56,455 | $ 101,671 | $ 113,522 | ||||
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | $ 76,368 | $ 538 | $ 81,934 | 4,860 | ||||
Abacus | ||||||||
Business Acquisition, Percentage of Voting Interests Acquired | 56.00% | 56.00% | ||||||
Business Combination, Consideration Transferred | $ 2,599 | |||||||
Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value | $ 1,838 | |||||||
Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Loss | 163 | |||||||
Goodwill, Acquired During Period | 4,662 | |||||||
Business Acquisition, Goodwill, Expected Tax Deductible Amount | 2,725 | 2,725 | ||||||
Payments to Acquire Businesses, Gross | 2,599 | |||||||
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net | $ (225) | $ (225) | ||||||
Torchlight Technology Group Acquisition Member | ||||||||
Business Acquisition, Percentage of Voting Interests Acquired | 77.00% | 77.00% | ||||||
Business Combination, Consideration Transferred | $ 11,628 | |||||||
Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value | 3,432 | |||||||
Goodwill, Acquired During Period | 11,122 | |||||||
Business Acquisition, Goodwill, Expected Tax Deductible Amount | $ 7,976 | 7,976 | ||||||
Payments to Acquire Businesses, Gross | 11,443 | |||||||
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net | 3,938 | 3,938 | ||||||
Business Combination, Consideration Transferred, Liabilities Incurred | $ 185 | |||||||
Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain | 519 | |||||||
Finite-lived Intangible Assets Acquired | $ 2,700 | |||||||
Revenues | 1,828 | |||||||
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | $ (564) |
Business Combination Disclosu_4
Business Combination Disclosure: Schedule of Recognized Identified Assets Acquired and Liabilities Assumed (Details) - USD ($) $ in Thousands | Apr. 30, 2020 | Jan. 31, 2020 |
Abacus | ||
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other | $ 350 | |
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets | 350 | |
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other | 575 | |
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities | 575 | |
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net | $ (225) | |
Torchlight Technology Group Acquisition Member | ||
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other | $ 2,132 | |
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets | 5,165 | |
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities | 1,227 | |
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net | 3,938 | |
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents | 333 | |
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles | 2,700 | |
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other | $ 1,227 |
Goodwill and Intangible Asset_4
Goodwill and Intangible Assets Disclosure [Text Block] (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | |||
Jun. 30, 2021 | Jun. 30, 2020 | Jun. 30, 2021 | Jun. 30, 2020 | Dec. 31, 2020 | |
Goodwill | $ 12,486 | $ 12,486 | $ 12,486 | ||
Intangible Assets, Net (Excluding Goodwill) | 3,667 | 3,667 | 4,008 | ||
Amortization of Intangible Assets | 179 | $ 171 | 341 | $ 224 | |
Specialty Health Segment Member | |||||
Goodwill | $ 8,263 | $ 8,263 | 8,263 | ||
Group Disability And Life Member | |||||
Goodwill | $ 4,223 |
Goodwill and Intangible Asset_5
Goodwill and Intangible Assets Disclosure [Text Block]: Schedule of Finite-Lived Intangible Assets (Details) - USD ($) $ in Thousands | Jun. 30, 2021 | Dec. 31, 2020 |
Finite-Lived Intangible Assets, Gross | $ 8,083 | $ 9,083 |
Finite-Lived Intangible Assets, Accumulated Amortization | 4,893 | 5,552 |
Customer Relationships | ||
Finite-Lived Intangible Assets, Gross | 6,583 | 7,583 |
Finite-Lived Intangible Assets, Accumulated Amortization | 4,599 | 5,385 |
Computer Software, Intangible Asset | ||
Finite-Lived Intangible Assets, Gross | 1,500 | 1,500 |
Finite-Lived Intangible Assets, Accumulated Amortization | $ 294 | $ 167 |
Goodwill and Intangible Asset_6
Goodwill and Intangible Assets Disclosure [Text Block]: Schedule of Indefinite-Lived Intangible Assets (Details) - USD ($) $ in Thousands | Jun. 30, 2021 | Dec. 31, 2020 |
Indefinite-lived Intangible Assets (Excluding Goodwill) | $ 477 | $ 477 |
Licensing Agreements | ||
Indefinite-lived Intangible Assets (Excluding Goodwill) | $ 477 | $ 477 |
Revenue from Contract with Cu_4
Revenue from Contract with Customer: Disaggregation of Revenue (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2021 | Jun. 30, 2020 | Jun. 30, 2021 | Jun. 30, 2020 | |
Insurance Commissions and Fees | $ 4,944 | $ 3,907 | $ 11,079 | $ 7,341 |
Commissions | ||||
Insurance Commissions and Fees | 1,416 | 1,932 | 4,297 | 3,672 |
Administrative Fees | ||||
Insurance Commissions and Fees | 80 | 581 | 177 | 1,069 |
Marketing Fees | ||||
Insurance Commissions and Fees | 254 | 292 | 559 | 643 |
Enrollment Platform Fees | ||||
Insurance Commissions and Fees | 529 | 455 | 1,029 | 973 |
Lead and Referral Fees | ||||
Insurance Commissions and Fees | 2,633 | 588 | 4,945 | 854 |
Payment Plan, Application and Other Fees | ||||
Insurance Commissions and Fees | $ 32 | $ 59 | $ 72 | $ 130 |
Revenue from Contract with Cu_5
Revenue from Contract with Customer (Details) - USD ($) $ in Thousands | Jun. 30, 2021 | Dec. 31, 2020 |
Accounts Payable and Accrued Liabilities | ||
Accrued Sales Commission, Estimated Expected Lifetime Commissions | $ 2,858 | $ 2,362 |
Revenue from Contract with Cu_6
Revenue from Contract with Customer: Contract with Customer, Contract Asset, Contract Liability, and Receivable (Details) $ in Thousands | 6 Months Ended |
Jun. 30, 2021USD ($) | |
Details | |
Contract with Customer, Asset, after Allowance for Credit Loss | $ 7,760 |
Contract with Customer, Asset, Increase (Decrease) for Revenues Recognized During the Year | 4,708 |
Contract With Customer Asset Increase (Decrease) For Revenue Recognized From Prior Periods | (418) |
Contract with Customer, Asset, Decrease for Cash Received During the Year | (3,251) |
Contract with Customer, Asset, after Allowance for Credit Loss | $ 8,799 |
Income Tax Disclosure _Text B_2
Income Tax Disclosure [Text Block] (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | |||
Jun. 30, 2021 | Jun. 30, 2020 | Jun. 30, 2021 | Jun. 30, 2020 | Dec. 31, 2020 | |
Discontinued Operation, Gain (Loss) from Disposal of Discontinued Operation, before Income Tax | $ (74,534) | $ 0 | |||
Discontinued Operations | |||||
Discontinued Operation, Gain (Loss) from Disposal of Discontinued Operation, before Income Tax | $ 74,534 | $ 0 | 74,534 | $ 0 | |
Discontinued Operation, Tax Effect of Gain (Loss) from Disposal of Discontinued Operation | 11,841 | ||||
Pets Sale, PetPartners Transaction | Discontinued Operations | |||||
Discontinued Operation, Gain (Loss) from Disposal of Discontinued Operation, before Income Tax | 74,534 | ||||
AMICSubsidiariesMember | |||||
Operating Loss Carryforwards | $ 46,116 | ||||
Deferred Tax Assets, Valuation Allowance | 8,281 | ||||
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | 8,281 | ||||
AMICSubsidiariesMember | Pets Sale, PetPartners Transaction | |||||
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | $ 8,281 | ||||
AMIC Holdiings | Domestic Tax Authority | |||||
Operating Loss Carryforwards | $ 46,116 |
Liability for Future Policy B_4
Liability for Future Policy Benefits and Unpaid Claims Disclosure [Text Block]: Schedule of Liability for Unpaid Claims and Claims Adjustment Expense (Details) - USD ($) $ in Thousands | 6 Months Ended | |
Jun. 30, 2021 | Jun. 30, 2020 | |
Liability for Claims and Claims Adjustment Expense, Beginning Balance | $ 132,957 | $ 135,483 |
Reinsurance Recoverable for Unpaid Claims and Claims Adjustments, Beginning Balance | 36,126 | 36,993 |
Liability for Unpaid Claims and Claims Adjustment Expense, Net, Beginning Balance | 96,831 | 98,490 |
Current Year Claims and Claims Adjustment Expense | 48,609 | 54,797 |
Prior Year Claims and Claims Adjustment Expense | (9,799) | (6,726) |
Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims | 38,810 | 48,071 |
Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Current Year | 15,268 | 16,053 |
Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Prior Years | 27,235 | 31,810 |
Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid | 42,503 | 47,863 |
Liability for Unpaid Claims and Claims Adjustment Expense, Net, Ending Balance | 93,138 | 98,698 |
Reinsurance Recoverable for Unpaid Claims and Claims Adjustments, Ending Balance | 34,677 | 35,339 |
Liability for Claims and Claims Adjustment Expense, Ending Balance | 127,815 | 134,037 |
Specialty Health Segment, All Product Lines | ||
Liability for Claims and Claims Adjustment Expense, Beginning Balance | 31,680 | 35,530 |
Reinsurance Recoverable for Unpaid Claims and Claims Adjustments, Beginning Balance | 1,776 | 1,717 |
Liability for Unpaid Claims and Claims Adjustment Expense, Net, Beginning Balance | 29,904 | 33,813 |
Current Year Claims and Claims Adjustment Expense | 16,631 | 24,522 |
Prior Year Claims and Claims Adjustment Expense | (4,634) | (1,972) |
Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims | 11,997 | 22,550 |
Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Current Year | 4,461 | 7,064 |
Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Prior Years | 12,080 | 17,530 |
Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid | 16,541 | 24,594 |
Liability for Unpaid Claims and Claims Adjustment Expense, Net, Ending Balance | 25,360 | 31,769 |
Reinsurance Recoverable for Unpaid Claims and Claims Adjustments, Ending Balance | 1,161 | 1,802 |
Liability for Claims and Claims Adjustment Expense, Ending Balance | 26,521 | 33,571 |
Group Disability Product Line | ||
Liability for Claims and Claims Adjustment Expense, Beginning Balance | 80,976 | 80,079 |
Reinsurance Recoverable for Unpaid Claims and Claims Adjustments, Beginning Balance | 22,472 | 23,322 |
Liability for Unpaid Claims and Claims Adjustment Expense, Net, Beginning Balance | 58,504 | 56,757 |
Current Year Claims and Claims Adjustment Expense | 20,031 | 19,093 |
Prior Year Claims and Claims Adjustment Expense | (4,033) | (1,553) |
Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims | 15,998 | 17,540 |
Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Current Year | 3,922 | 4,010 |
Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Prior Years | 11,488 | 12,125 |
Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid | 15,410 | 16,135 |
Liability for Unpaid Claims and Claims Adjustment Expense, Net, Ending Balance | 59,092 | 58,162 |
Reinsurance Recoverable for Unpaid Claims and Claims Adjustments, Ending Balance | 22,492 | 22,463 |
Liability for Claims and Claims Adjustment Expense, Ending Balance | 81,584 | 80,625 |
Other Short Duration Contract Product Lines | ||
Liability for Claims and Claims Adjustment Expense, Beginning Balance | 20,301 | 19,874 |
Reinsurance Recoverable for Unpaid Claims and Claims Adjustments, Beginning Balance | 11,878 | 11,954 |
Liability for Unpaid Claims and Claims Adjustment Expense, Net, Beginning Balance | 8,423 | 7,920 |
Current Year Claims and Claims Adjustment Expense | 11,947 | 11,182 |
Prior Year Claims and Claims Adjustment Expense | (1,132) | (3,201) |
Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims | 10,815 | 7,981 |
Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Current Year | 6,885 | 4,979 |
Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Prior Years | 3,667 | 2,155 |
Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid | 10,552 | 7,134 |
Liability for Unpaid Claims and Claims Adjustment Expense, Net, Ending Balance | 8,686 | 8,767 |
Reinsurance Recoverable for Unpaid Claims and Claims Adjustments, Ending Balance | 11,024 | 11,074 |
Liability for Claims and Claims Adjustment Expense, Ending Balance | 19,710 | 19,841 |
Health Insurance Product Line | Specialty Health Segment Member | ||
Liability for Claims and Claims Adjustment Expense, Beginning Balance | 28,295 | 31,259 |
Reinsurance Recoverable for Unpaid Claims and Claims Adjustments, Beginning Balance | 1,766 | 1,113 |
Liability for Unpaid Claims and Claims Adjustment Expense, Net, Beginning Balance | 26,529 | 30,146 |
Current Year Claims and Claims Adjustment Expense | 15,818 | 23,627 |
Prior Year Claims and Claims Adjustment Expense | (3,658) | (1,184) |
Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims | 12,160 | 22,443 |
Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Current Year | 4,319 | 8,260 |
Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Prior Years | 11,992 | 16,382 |
Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid | 16,311 | 24,642 |
Liability for Unpaid Claims and Claims Adjustment Expense, Net, Ending Balance | 22,378 | 27,947 |
Reinsurance Recoverable for Unpaid Claims and Claims Adjustments, Ending Balance | 1,158 | 1,406 |
Liability for Claims and Claims Adjustment Expense, Ending Balance | $ 23,536 | $ 29,353 |
Liability for Future Policy B_5
Liability for Future Policy Benefits and Unpaid Claims Disclosure [Text Block]: Schedule Of Prior Year Claims And Claims Adjustment Expense Disclosure (Details) - USD ($) $ in Thousands | 6 Months Ended | |
Jun. 30, 2021 | Jun. 30, 2020 | |
Prior Year Claims and Claims Adjustment Expense | $ (9,799) | $ (6,726) |
Specialty Health, Short-Term Medical Product Line | ||
Prior Year Claims and Claims Adjustment Expense | (1,676) | (286) |
Specialty Health, Occupational Accident Product Line | ||
Prior Year Claims and Claims Adjustment Expense | (963) | (798) |
Specialty Health, Fixed Indemnity Limited Benefit Product Line | ||
Prior Year Claims and Claims Adjustment Expense | (862) | 736 |
Specialty Health, Limited Medical Product Line | ||
Prior Year Claims and Claims Adjustment Expense | (197) | (241) |
Specialty Health, Critical Illness Product Line | ||
Prior Year Claims and Claims Adjustment Expense | (196) | (397) |
Specialty Health, Group Gap Product Line | ||
Prior Year Claims and Claims Adjustment Expense | (356) | (513) |
Specialty Health, Other Specialty Health Product Lines | ||
Prior Year Claims and Claims Adjustment Expense | (384) | (473) |
Specialty Health Segment, All Product Lines | ||
Prior Year Claims and Claims Adjustment Expense | $ (4,634) | $ (1,972) |
Liability for Future Policy B_6
Liability for Future Policy Benefits and Unpaid Claims Disclosure [Text Block] (Details) - USD ($) $ in Thousands | 6 Months Ended | |
Jun. 30, 2021 | Jun. 30, 2020 | |
Prior Year Claims and Claims Adjustment Expense | $ (9,799) | $ (6,726) |
Group Disability Product Line | ||
Prior Year Claims and Claims Adjustment Expense | (4,033) | (1,553) |
Health Insurance Product Line | Specialty Health Segment Member | ||
Prior Year Claims and Claims Adjustment Expense | (3,658) | $ (1,184) |
Short-duration Insurance Contracts, Incurred but Not Reported (IBNR) Claims Liability, Net | $ 22,378 |
Stockholders' Equity Note Dis_4
Stockholders' Equity Note Disclosure [Text Block]: Schedule of Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2021 | Jun. 30, 2020 | Jun. 30, 2021 | Jun. 30, 2020 | |
Accumulated other comprehensive income (loss) | $ 4,197 | |||
Other Comprehensive Income (Loss), Net of Tax | $ 952 | $ 1,753 | (977) | $ 1,642 |
Accumulated other comprehensive income (loss) | 3,220 | 3,220 | ||
AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent | ||||
Accumulated other comprehensive income (loss) | 2,268 | 1,101 | 4,197 | 1,212 |
Other Comprehensive Income (Loss), before Reclassifications, Net of Tax | 784 | 1,810 | (1,013) | 2,544 |
Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax | (168) | 57 | (36) | 902 |
Other Comprehensive Income (Loss), Net of Tax | 952 | 1,753 | (977) | 1,642 |
Accumulated other comprehensive income (loss) | $ 3,220 | $ 2,854 | $ 3,220 | $ 2,854 |
Stockholders' Equity Note Dis_5
Stockholders' Equity Note Disclosure [Text Block]: Reclassification out of Accumulated Other Comprehensive Income (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2021 | Jun. 30, 2020 | Jun. 30, 2021 | Jun. 30, 2020 | |
Gain (Loss) on Investments | $ (126) | $ 274 | $ 91 | $ 117 |
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | (704) | (2,858) | (1,044) | (3,140) |
Income Tax Expense (Benefit) | (267) | (1,066) | (430) | (1,187) |
Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | (437) | (1,792) | (614) | (1,953) |
Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax | 92,375 | 3,594 | 99,574 | 9,243 |
Discontinued Operation, Tax Effect of Discontinued Operation | 15,570 | 1,264 | 17,026 | 2,430 |
Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | 76,805 | 2,330 | 82,548 | 6,813 |
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | 76,368 | 538 | 81,934 | 4,860 |
Reclassification out of Accumulated Other Comprehensive Income | AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent | ||||
Gain (Loss) on Investments | (125) | 47 | 47 | 284 |
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | (125) | 47 | 47 | 284 |
Income Tax Expense (Benefit) | (28) | 10 | 9 | 60 |
Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | (97) | 37 | 38 | 224 |
Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax | (90) | 25 | (94) | 858 |
Discontinued Operation, Tax Effect of Discontinued Operation | (19) | 5 | (20) | 180 |
Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | (71) | 20 | (74) | 678 |
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | $ (168) | $ 57 | $ (36) | $ 902 |
Cash Flow, Supplemental Discl_2
Cash Flow, Supplemental Disclosures [Text Block] (Details) - USD ($) $ in Thousands | 6 Months Ended | |
Jun. 30, 2021 | Jun. 30, 2020 | |
Details | ||
Income Taxes Paid (Refunds), Net | $ 59 | $ 55 |
Commitments and Contingencies_2
Commitments and Contingencies Disclosure [Text Block] (Details) - USD ($) $ in Thousands | 1 Months Ended | 3 Months Ended | ||
Oct. 31, 2020 | Sep. 30, 2020 | May 31, 2017 | Sep. 30, 2020 | |
Accounts Payable and Accrued Liabilities | ||||
Loss Contingency Accrual, Provision | $ 3,660 | |||
Loss Contingency Accrual, Payments | $ 3,660 | |||
Other Income | ||||
Gain (Loss) Related to Litigation Settlement | $ 5,641 | |||
Pending Litigation | Loss Contingency, Nature, Amounts Allegedly Owed To Plaintiff Member | ||||
Loss Contingency, Damages Sought, Value | $ 3,082 |
Segment Reporting Disclosure _3
Segment Reporting Disclosure [Text Block]: Schedule of Segment Reporting Information, by Segment (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2021 | Jun. 30, 2020 | Jun. 30, 2021 | Jun. 30, 2020 | |
Revenues | $ 49,330 | $ 56,455 | $ 101,671 | $ 113,522 |
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | (704) | (2,858) | (1,044) | (3,140) |
Operating Segments | ||||
Revenues | 49,456 | 56,181 | 101,580 | 113,405 |
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | (578) | (3,132) | (1,135) | (3,257) |
Segment Reconciling Items | Gain (Loss) on Investments | ||||
Revenues | (126) | 274 | 91 | 117 |
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | (126) | 274 | 91 | 117 |
Specialty Health Segment Member | ||||
Revenues | 23,862 | 30,718 | 50,133 | 62,924 |
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | (841) | (5,329) | (2,732) | (5,935) |
Group Disability And Life Member | ||||
Revenues | 25,143 | 24,076 | 50,264 | 48,161 |
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | 3,770 | 4,353 | 6,900 | 6,190 |
Individual life annuities and other Segment Member | ||||
Revenues | 183 | 490 | 392 | 808 |
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | (263) | (140) | (247) | (283) |
Amortization of Other Deferred Charges | 153 | 176 | 310 | 364 |
Corporate Segment | ||||
Revenues | 268 | 897 | 791 | 1,512 |
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | $ (3,244) | $ (2,016) | $ (5,056) | $ (3,229) |
Subsequent Events _Text Block_
Subsequent Events [Text Block] (Details) - MNL Sale - Discontinued Operations $ in Thousands | Jul. 14, 2021USD ($) |
Disposal Group Including Discontinued Operation, Transaction Price | $ 172,500 |
Disposal Group Including Discontinued Operation, Transaction Price, Potential Earn Out | $ 12,500 |